rfhg_135879.1

Basic information about the TSS

---

TSS ID: rfhg_135879.1 Species: human Chr: chr11		Start: 35219327 End: 35219360 Strand: +
Source datasets	PRJDB5282
Protocol	C1CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	dELS (EH38D2441291,EH38E1532607)
Category:	dELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000525469.1:0 GeneID: 960 HGNC/MGI_ID: HGNC:1681 UniProt_ID: H0YE40 Nearer transcript ids and distances: LQ969664:-11 ENST00000531141.1:-398 view more...

Gene_name: CD44 molecule (Indian blood group) Gene_symbol: CD44 Gene_synonyms: CD44R CDw44 CSPG8 ECM-III H-CAM HCELL HUTCH-1 HUTCH-I Hermes-1 IN MC56 PGP-1 Pgp1 Gene_source: HGNC:1681

TATA-Box annotation

---

Distance to TSS:	56393
Nearest PromoterID:	NR_145794
Entrez ID:	109623487
Nearest Unigene:
Nearest Refseq:	NR_145794
Nearest Ensembl:
Gene Name:	CD44 molecule (Indian blood group)
Gene Alias:	-
Gene Type:	snoRNA
CpG%:	0.000000
GC%:	0.529412
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CD44 p2@CD44 p3@CD44 p5@CD44 p7@CD44 p8@CD44 p10@CD44
Sample		p1@CD44	p2@CD44	p3@CD44	p5@CD44	p7@CD44	p8@CD44	p10@CD44
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	20.45	0.19	0.39	0.19	0.00	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	17.20	0.40	0.20	0.00	0.61	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	22.38	0.58	0.19	0.19	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	37.42	0.62	0.21	0.42	0.21	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	41.17	0.22	0.67	0.22	0.22	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	44.19	0.39	0.00	0.39	0.39	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	287.39	4.36	5.01	1.74	1.53	0.65	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	261.11	3.63	2.91	1.70	2.66	0.73	0.97
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	249.19	2.78	2.78	1.07	1.92	0.85	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	201.13	0.58	1.16	1.74	0.58	1.16	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	184.74	2.43	1.21	1.21	1.21	0.40	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	171.16	0.81	1.63	0.81	2.03	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	388.96	8.22	4.84	1.93	1.61	1.61	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	403.24	7.82	4.96	3.16	3.31	1.35	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	369.73	10.10	4.61	1.98	0.88	0.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	393.83	9.56	9.05	3.52	1.76	2.01	2.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	405.36	8.52	6.33	2.62	2.40	1.31	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	417.18	14.34	4.64	7.17	2.11	1.69	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	394.00	10.13	9.60	3.73	2.13	1.60	3.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	340.75	11.43	4.51	3.61	1.96	1.96	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	372.49	9.49	5.08	3.34	1.74	1.74	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	357.68	12.60	4.49	3.63	2.24	1.04	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	411.04	7.63	6.46	3.75	1.94	0.90	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	355.02	9.71	4.13	2.67	1.46	0.49	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	352.67	6.45	6.71	3.61	1.29	1.03	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	345.63	7.60	5.70	4.11	0.32	0.63	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	396.71	19.78	6.59	5.49	3.30	1.10	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	439.44	5.66	5.19	2.36	0.94	2.12	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	384.75	7.59	5.01	2.91	1.78	1.94	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	386.72	7.24	5.25	3.44	2.17	1.27	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	438.16	11.93	5.44	4.40	3.98	2.09	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	398.97	10.16	4.30	2.93	2.34	2.15	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	490.85	14.77	4.22	7.39	3.38	2.11	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	603.51	12.87	9.90	5.61	3.46	1.81	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	438.68	14.21	8.41	3.93	3.18	1.87	1.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	467.94	11.11	6.71	4.79	2.68	1.15	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	489.69	14.10	8.38	4.50	3.47	2.25	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	491.43	12.69	10.07	3.02	4.84	2.22	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	521.57	18.10	8.10	5.94	5.94	3.24	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	452.28	14.16	5.76	3.84	3.12	3.12	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	485.11	11.29	5.88	6.12	0.94	2.35	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	559.96	11.27	10.54	5.12	1.61	2.64	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	472.40	15.82	10.12	2.95	2.95	2.11	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	520.11	14.51	8.04	3.85	2.45	3.15	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	489.68	16.06	8.03	4.22	2.01	1.61	2.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	486.70	21.40	12.10	6.75	3.72	2.09	2.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	534.03	14.15	4.56	4.56	2.88	1.68	2.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	462.28	13.11	6.26	1.79	2.98	0.89	2.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	562.77	12.45	9.81	2.15	2.87	3.11	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	544.52	10.11	9.30	4.04	3.84	2.63	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	535.13	36.89	19.68	8.20	12.30	5.53	2.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	582.40	22.68	12.01	11.56	6.89	3.11	3.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	461.74	55.97	55.97	125.93	27.98	41.98	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	675.65	37.61	17.39	10.29	8.87	7.81	2.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	590.20	24.52	16.24	9.28	6.30	4.64	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	937.09	38.59	43.62	25.17	20.13	15.10	12.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	628.24	25.26	22.50	10.10	12.86	6.89	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	590.20	37.27	15.23	10.70	9.72	6.48	4.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	524.79	20.23	13.81	6.42	4.82	6.10	1.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	592.20	14.46	14.46	7.23	7.54	6.92	3.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	501.29	19.04	11.99	6.35	4.94	8.46	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	514.80	25.24	12.90	2.24	5.05	3.93	2.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	582.78	16.72	20.70	11.15	16.72	6.37	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	388.69	18.35	12.57	6.46	6.12	3.74	2.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	415.57	18.85	8.45	6.50	5.52	7.47	4.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	351.43	15.26	13.49	8.52	3.55	1.06	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	193.97	48.49	0.00	32.33	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	300.10	39.49	0.00	39.49	0.00	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	819.51	39.49	16.58	13.16	13.65	8.29	3.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	751.74	34.71	13.88	7.93	14.38	7.93	5.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	853.32	20.64	7.51	5.16	4.22	8.44	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	1068.42	33.45	21.20	11.26	14.24	11.59	8.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	1186.01	81.67	34.96	10.52	18.25	19.18	5.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	1199.74	44.94	24.15	16.51	10.40	11.01	7.03
Adipocyte - breast, donor1	11376-118A8	323.42	3.80	6.18	1.74	0.63	0.00	0.48
Adipocyte - breast, donor2	11327-117E4	232.94	11.87	6.42	2.73	1.76	1.93	1.93
Adipocyte - omental, donor1	11473-119C6	225.32	2.67	3.56	0.25	1.40	0.38	0.25
Adipocyte - omental, donor2	11474-119C7	274.33	5.98	3.74	0.75	2.24	1.49	1.49
Adipocyte - omental, donor3	11475-119C8	60.96	1.34	1.34	0.33	0.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	245.63	3.83	7.02	1.91	1.28	1.28	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	69.27	2.20	1.10	1.10	1.10	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	652.15	6.32	10.39	1.35	0.45	0.45	1.81
Adipocyte - subcutaneous, donor3	11408-118E4	660.17	7.99	7.30	2.43	2.26	1.39	1.56
Adipocyte differentiation, day04, donor1	13019-139D4	615.46	5.48	7.82	1.76	1.76	0.59	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	574.21	7.98	4.89	2.57	0.77	2.06	1.54
Adipocyte differentiation, day04, donor3	13025-139E1	796.45	7.25	5.58	2.51	3.07	2.23	1.95
Adipocyte differentiation, day04, donor4	13028-139E4	918.75	8.23	4.70	0.59	2.35	1.18	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	272.67	2.33	2.57	0.80	0.64	0.24	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	602.91	7.10	5.49	3.55	6.13	1.61	1.61
Adipocyte differentiation, day08, donor3	13026-139E2	454.28	12.80	11.20	3.20	1.60	1.60	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	489.11	5.01	2.78	3.34	1.67	1.11	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	208.36	3.33	2.08	0.83	0.42	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	455.11	6.28	4.02	1.51	2.26	1.00	1.00
Adipocyte differentiation, day12, donor3	13027-139E3	320.70	6.22	3.93	2.62	0.65	1.64	1.31
Adipocyte differentiation, day12, donor4	13030-139E6	219.83	2.13	2.13	0.30	0.61	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	558.68	5.30	2.21	1.99	0.66	1.10	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	89.29	0.72	0.00	0.36	0.00	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	415.71	7.19	2.40	1.20	1.20	3.59	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	89.05	0.54	0.54	0.18	0.00	0.18	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	18.41	1.67	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	98.20	0.41	0.21	0.41	0.21	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	842.63	7.90	5.49	2.52	1.60	2.63	2.06
Anulus Pulposus Cell, donor2	11463-119B5	877.75	15.18	4.41	3.92	4.41	1.96	1.96
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	651.93	38.64	10.78	8.99	5.84	3.59	5.84
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	806.20	21.71	8.25	2.60	4.78	3.91	2.17
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	545.76	32.10	4.28	4.28	2.14	4.28	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	689.31	29.89	15.25	5.38	5.38	4.48	2.09
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	708.21	53.12	13.91	10.12	10.12	5.06	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	502.31	19.80	6.60	8.58	3.96	1.98	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	619.88	22.42	9.10	2.92	2.27	1.30	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	683.50	20.87	10.68	5.83	3.40	2.43	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	564.18	22.57	3.56	5.94	3.56	2.38	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	655.35	37.29	16.57	5.27	7.91	3.39	3.77
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	671.97	15.96	3.63	7.98	6.53	1.45	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	458.88	22.57	10.03	8.78	2.51	2.51	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	721.38	2.64	3.46	1.32	3.13	0.66	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	656.47	12.28	8.19	9.55	5.46	5.46	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	481.63	2.41	1.81	1.96	0.45	1.21	0.60
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	671.34	21.43	14.47	5.36	4.82	1.07	2.68
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	561.14	13.98	4.91	4.35	5.67	2.83	1.32
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	578.41	19.24	8.82	4.28	5.61	2.41	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	644.77	17.56	7.80	2.93	0.98	0.00	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	562.10	10.12	5.31	2.49	4.64	2.82	1.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	505.50	21.61	7.20	7.20	4.80	3.60	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	513.32	24.78	7.08	7.08	7.08	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	621.62	11.66	4.29	4.80	2.92	2.92	1.89
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	469.84	4.19	4.19	0.00	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	652.41	44.66	13.11	7.28	5.34	6.31	3.88
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	631.79	14.42	4.17	3.42	3.04	2.66	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	513.62	29.07	10.90	15.75	3.63	3.63	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	560.91	16.53	5.13	2.28	3.99	1.71	2.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	564.58	13.04	5.13	4.06	4.28	1.50	1.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	429.98	11.36	2.32	2.58	2.84	2.06	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	634.84	23.46	7.98	6.10	6.57	3.28	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	603.87	15.43	5.79	2.89	2.25	1.93	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	462.32	9.99	1.43	3.57	3.57	2.14	4.28
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	661.58	17.55	7.60	1.75	3.51	4.09	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	589.80	13.55	4.52	3.01	4.82	2.41	2.11
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	463.32	19.01	7.13	3.56	3.56	3.56	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	659.09	38.65	13.73	5.59	4.58	5.09	4.07
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	588.33	26.49	8.15	6.62	3.82	3.06	2.80
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	446.66	12.07	5.08	3.18	1.91	3.18	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	674.49	22.44	11.65	4.32	3.02	3.02	1.73
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	556.73	11.22	4.66	2.33	3.60	1.91	2.12
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	457.01	11.31	3.77	2.90	3.19	1.16	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	683.04	17.95	9.45	1.89	4.72	5.67	2.83
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	550.11	6.27	2.54	3.73	2.37	2.37	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	560.56	18.53	9.27	9.27	6.95	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	669.69	19.01	14.79	4.23	4.23	6.34	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	634.45	10.72	6.00	2.36	3.86	1.50	1.50
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	606.48	12.63	6.62	4.21	3.01	2.41	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	696.17	34.26	13.85	3.64	7.29	5.83	2.19
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	725.27	17.01	8.05	3.45	3.45	2.07	2.30
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	762.54	53.56	12.75	20.40	10.20	7.65	7.65
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	666.85	5.59	2.29	3.56	2.80	1.27	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	760.32	15.48	6.19	3.72	5.57	2.68	1.86
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	597.31	16.52	7.34	4.90	2.75	3.67	1.84
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	729.92	43.50	12.91	5.26	5.74	6.69	2.39
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	580.29	13.53	5.77	5.32	3.10	2.00	1.33
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	601.16	18.31	7.63	1.53	6.10	4.58	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	665.77	12.19	8.31	4.43	4.43	2.77	2.22
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	626.50	11.92	3.44	4.24	4.24	1.85	2.38
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	610.96	25.80	6.18	5.09	4.00	1.45	0.00
Astrocyte - cerebellum, donor1	11500-119F6	885.75	3.81	2.33	1.60	0.61	1.35	0.37
Astrocyte - cerebellum, donor2	11580-120F5	568.59	7.87	4.28	1.54	3.08	1.03	1.03
Astrocyte - cerebellum, donor3	11661-122F5	472.14	3.36	3.99	2.31	1.26	0.21	0.84
Astrocyte - cerebral cortex, donor1	11235-116D2	729.94	6.27	5.58	2.09	0.35	1.05	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	1053.15	26.69	17.15	6.79	6.63	3.88	2.59
Astrocyte - cerebral cortex, donor3	11392-118C6	699.86	13.28	7.91	3.88	2.68	1.49	2.09
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	227.19	5.96	3.90	1.15	1.49	1.38	0.69
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	263.22	4.89	2.63	1.00	1.13	0.50	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	235.33	4.21	2.16	0.68	1.14	1.14	0.57
Basophils, donor1	12241-129G9	1120.14	2.62	4.45	2.62	1.31	0.52	0.52
Basophils, donor2	12242-129H1	1619.25	8.66	4.69	1.08	3.25	0.36	2.16
Basophils, donor3	12243-129H2	1392.80	6.03	3.97	1.18	2.06	1.62	2.06
Bronchial Epithelial Cell, donor1	11511-119G8	531.46	3.67	1.94	3.23	0.86	0.86	1.08
Bronchial Epithelial Cell, donor2	11591-120G7	389.52	5.94	0.91	1.83	0.46	0.91	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	566.71	14.35	7.17	7.17	0.00	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	336.42	3.77	2.51	1.88	1.26	1.26	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	550.44	6.03	4.99	2.91	3.74	0.21	1.04
Bronchial Epithelial Cell, donor6	11461-119B3	564.90	12.67	10.82	7.83	5.07	2.76	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	569.35	16.55	7.02	11.34	4.32	3.24	2.70
Burkitt's lymphoma cell line:DAUDI	10422-106C8	22.36	0.21	0.10	0.00	0.00	0.00	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	544.58	1.60	0.96	1.92	1.28	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	951.46	0.00	0.00	0.00	0.00	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	1922.29	7.89	3.38	3.38	1.13	1.69	2.25
CD14+ Monocytes, donor2	11305-117B9	2486.12	36.38	22.09	7.98	8.91	4.64	5.01
CD14+ Monocytes, donor3	11381-118B4	1783.95	12.73	4.83	7.24	5.49	2.85	3.29
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	612.79	4.53	12.74	3.11	1.70	0.85	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	655.80	4.17	13.65	1.52	1.14	0.76	1.52
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	736.05	6.57	14.79	1.97	1.64	1.64	1.31
CD14+ monocytes - mock treated, donor1	11863-125A9	2257.13	58.83	47.27	17.78	11.13	11.56	7.81
CD14+ monocytes - mock treated, donor2	11873-125C1	1691.27	43.45	32.59	8.75	8.45	5.13	7.54
CD14+ monocytes - mock treated, donor3	11883-125D2	2139.62	40.75	33.88	8.05	10.90	6.87	5.21
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	2528.21	57.75	37.33	10.88	10.55	11.38	5.69
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	2001.36	40.85	30.64	9.11	9.38	7.45	3.59
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	2868.29	40.66	30.00	12.64	13.88	8.43	4.71
CD14+ monocytes - treated with BCG, donor1	11860-125A6	2316.91	41.31	31.13	12.92	10.18	9.01	7.05
CD14+ monocytes - treated with BCG, donor2	11870-125B7	2005.18	40.60	28.84	9.08	12.46	7.66	3.74
CD14+ monocytes - treated with BCG, donor3	11880-125C8	2730.39	44.40	23.50	15.45	10.23	6.75	2.18
CD14+ monocytes - treated with Candida, donor1	11868-125B5	3356.21	43.08	29.73	17.33	11.71	7.49	4.92
CD14+ monocytes - treated with Candida, donor2	11878-125C6	3613.82	55.44	30.10	19.01	13.73	5.81	8.98
CD14+ monocytes - treated with Candida, donor3	11888-125D7	3746.30	32.17	18.86	22.19	11.09	12.20	5.55
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	2346.51	68.42	42.24	25.73	12.94	11.45	7.44
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	1806.51	38.71	30.93	12.37	6.59	8.18	4.19
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	2197.96	40.81	18.74	9.99	7.29	8.33	3.33
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	3722.56	89.00	59.71	22.65	19.22	17.16	6.18
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	3149.21	38.45	28.05	8.14	11.31	3.85	2.49
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	3522.24	58.05	35.79	19.20	11.78	8.29	7.42
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	2007.47	55.95	32.55	14.79	14.79	7.80	5.65
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	1917.14	53.21	33.50	13.78	10.82	6.63	3.66
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	2307.78	50.08	34.09	14.73	13.05	9.68	6.73
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	4023.82	72.38	47.21	33.07	19.11	14.88	9.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	3901.34	63.41	39.10	16.56	19.37	5.64	4.58
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	5197.58	87.75	56.60	22.81	22.81	14.04	9.21
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	2194.50	49.00	30.52	15.69	11.51	8.02	5.23
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	1812.30	40.51	25.65	16.73	8.92	13.38	4.83
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	2501.67	41.82	25.00	12.07	7.98	6.68	3.66
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	3228.40	56.10	50.37	24.98	15.56	14.33	6.14
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	3544.21	39.17	26.19	10.20	9.97	5.56	3.01
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	3611.42	58.46	29.23	19.49	12.06	11.60	4.87
CD14+CD16+ Monocytes, donor1	11789-124B7	673.73	7.63	6.76	3.27	2.18	3.05	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	764.13	9.70	4.62	2.31	1.85	2.31	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	671.08	3.68	0.65	2.17	0.43	0.22	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	1524.99	9.81	11.06	4.67	2.34	2.34	1.40
CD14+CD16- Monocytes, donor2	11799-124C8	1376.72	9.43	8.91	3.49	2.45	1.05	1.05
CD14+CD16- Monocytes, donor3	11910-125G2	1940.05	25.86	14.72	4.46	6.02	4.01	3.57
CD14-CD16+ Monocytes, donor1	11790-124B8	688.72	2.04	2.30	1.02	1.02	0.77	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	846.42	7.03	6.59	1.98	3.51	1.32	1.54
CD14-CD16+ Monocytes, donor3	11911-125G3	782.60	3.58	1.89	0.63	2.74	0.84	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	400.37	0.00	0.00	4.06	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	367.46	3.39	0.68	1.36	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	410.10	2.07	2.07	0.00	0.00	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	370.46	2.67	1.07	3.20	0.00	0.53	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	499.08	2.68	0.54	0.54	1.07	1.07	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	401.51	1.40	2.11	0.70	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	433.75	3.92	3.14	2.35	1.57	0.78	3.14
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	425.81	0.00	1.32	1.32	2.64	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	867.93	9.04	6.58	0.82	1.64	1.64	1.64
CD19+ B Cells, donor2	11624-122B4	945.96	6.53	4.35	4.35	5.08	1.45	3.63
CD19+ B Cells, donor3	11705-123B4	913.74	14.14	2.52	5.55	3.03	1.01	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	120.00	0.40	0.40	0.00	0.81	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	83.49	0.00	0.80	0.00	0.40	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	556.24	0.00	2.01	2.01	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	1407.33	4.49	5.06	2.25	1.12	0.56	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	355.84	1.50	0.75	1.88	1.50	0.75	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	407.45	1.80	1.35	0.45	0.90	0.00	0.68
CD4+ T Cells, donor1	11225-116C1	1845.27	7.50	3.93	4.64	2.14	0.71	1.79
CD4+ T Cells, donor2	11306-117C1	2043.46	63.69	32.46	22.66	17.15	10.41	4.90
CD4+ T Cells, donor3	11382-118B5	1721.69	30.50	17.38	9.76	7.62	7.32	3.66
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	666.68	8.17	9.70	3.06	2.04	1.53	1.53
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	613.38	4.49	3.37	1.12	1.12	0.67	0.90
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	723.25	5.17	4.60	3.45	0.57	0.86	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	1306.59	6.64	5.69	4.74	2.37	1.90	2.84
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	1308.43	9.13	2.11	3.51	2.81	0.70	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	1127.31	3.30	3.30	3.30	3.30	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	665.64	9.97	10.41	2.89	1.59	2.75	1.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	514.83	5.93	7.63	4.91	1.19	1.53	1.53
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	421.39	6.77	5.48	2.42	1.93	1.93	1.29
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	1267.79	13.00	6.72	5.83	3.14	2.24	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	1459.39	11.53	6.99	7.34	4.19	1.40	1.75
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	1495.06	14.08	10.12	6.60	3.96	3.52	2.20
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	1036.39	12.65	10.12	2.95	2.53	2.11	1.26
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	587.99	7.48	7.27	4.16	2.49	2.49	1.66
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	681.95	9.36	6.01	4.34	5.35	2.00	2.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	1576.40	11.69	8.70	4.35	3.26	3.54	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	1615.89	13.40	8.04	4.29	3.75	2.14	3.22
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	1251.67	12.55	5.38	3.59	1.79	3.59	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	814.40	8.53	4.82	4.08	2.41	1.48	1.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	523.35	4.98	4.77	1.52	1.95	1.08	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	548.92	4.62	4.20	1.89	0.84	1.26	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	1275.13	8.09	8.60	4.55	0.51	2.53	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	1208.34	3.47	3.90	3.03	1.73	1.30	1.73
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	1392.43	16.56	9.59	3.49	4.36	1.31	2.61
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	1021.41	4.95	5.94	1.48	4.45	0.99	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	797.63	4.62	7.39	1.85	0.92	0.92	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	665.81	6.98	1.40	2.79	1.40	2.79	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	1460.52	6.65	9.14	1.38	2.77	2.49	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	1442.65	12.51	8.10	3.68	4.17	1.72	0.98
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	1050.28	3.08	4.62	0.00	3.08	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	1097.27	10.39	8.95	3.22	3.22	2.51	1.79
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	890.55	0.00	5.54	1.38	1.38	2.77	0.00
CD8+ T Cells, donor1	11226-116C2	1516.50	7.20	3.27	5.89	1.31	1.31	2.62
CD8+ T Cells, donor2	11307-117C2	1469.44	40.55	20.65	11.64	7.13	6.01	3.75
CD8+ T Cells, donor3	11383-118B6	1383.89	12.88	11.36	4.04	4.29	2.27	1.26
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	190.62	1.38	1.38	0.69	1.15	0.69	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	168.23	2.88	3.59	2.64	0.72	0.48	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	191.51	3.01	3.01	1.64	1.92	1.09	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	291.81	3.90	3.30	1.20	1.80	1.20	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	256.78	3.36	1.92	0.72	1.20	0.24	0.96
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	248.31	2.73	2.27	1.36	1.59	1.36	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	193.60	3.26	1.74	1.09	1.09	0.43	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	202.14	1.32	1.05	1.32	1.05	0.53	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	190.19	2.11	0.94	0.23	0.94	1.17	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	168.75	1.51	1.21	0.00	2.11	0.30	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	161.81	2.61	1.16	0.87	1.16	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	184.11	1.07	2.13	0.80	1.33	1.07	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	260.02	0.88	1.31	0.00	1.75	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	249.12	3.64	1.37	0.00	0.00	0.00	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	261.80	3.73	0.75	0.00	0.00	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	278.04	2.88	2.52	1.08	1.80	0.72	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	248.02	3.16	2.88	1.15	0.29	1.44	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	254.55	2.59	1.41	1.18	0.71	0.94	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	254.47	4.75	0.32	1.27	2.85	0.63	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	231.90	1.23	2.15	0.92	1.23	1.23	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	238.19	3.85	0.64	0.00	0.64	0.00	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	188.94	1.91	3.06	1.91	0.76	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	173.80	0.79	0.39	1.18	0.39	0.79	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	164.90	5.29	1.51	0.00	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	142.12	0.00	0.80	0.80	0.80	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	134.99	0.70	0.70	0.00	1.40	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	176.31	2.00	0.00	1.00	2.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	402.10	7.31	3.66	1.83	7.31	5.48	3.66
Cardiac Myocyte, donor2	11605-120I3	86.47	2.47	0.49	0.49	0.99	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	72.08	0.11	0.11	0.11	0.32	0.32	0.11
Chondrocyte - de diff, donor1	11261-116G1	1723.63	22.19	21.84	8.67	5.89	2.43	3.12
Chondrocyte - de diff, donor2	11338-117F6	970.53	6.75	6.40	4.26	2.84	1.07	1.78
Chondrocyte - de diff, donor3	11410-118E6	1083.97	18.89	17.86	4.78	3.98	2.84	2.39
Chondrocyte - re diff, donor2	11339-117F7	1228.29	18.80	5.37	3.58	2.69	2.69	2.69
Chondrocyte - re diff, donor3	11411-118E7	847.63	12.94	11.32	5.66	3.64	2.43	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	205.53	1.49	0.80	1.26	0.34	1.03	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	239.85	5.77	4.49	3.42	1.92	0.64	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	199.56	3.01	2.21	1.33	0.53	0.62	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	330.86	4.13	1.93	0.55	1.28	0.37	0.73
Corneal Epithelial Cells, donor1	11526-119I5	670.57	3.51	1.98	3.07	0.44	0.66	0.22
Corneal Epithelial Cells, donor2	11606-120I4	357.21	11.38	4.55	6.83	1.14	2.28	0.00
Corneal Epithelial Cells, donor3	11687-122I4	435.59	5.37	4.35	4.09	1.02	2.05	1.02
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	1346.85	10.24	8.58	3.80	1.98	1.49	1.32
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	1249.34	7.89	4.73	2.84	1.26	1.89	2.52
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	1269.86	0.00	3.45	3.45	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	939.83	17.71	12.74	6.70	4.00	4.97	2.70
Dendritic Cells - plasmacytoid, donor1	11228-116C4	554.83	2.73	3.07	3.07	0.68	1.02	1.37
Dendritic Cells - plasmacytoid, donor2	11309-117C4	295.75	0.65	0.00	1.31	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	529.92	1.45	2.42	2.42	0.97	0.48	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	123.41	0.33	0.50	0.17	0.00	0.00	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	271.09	1.17	1.17	1.76	0.59	1.17	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	346.43	1.70	0.57	0.28	0.85	0.28	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	184.01	0.79	1.57	0.79	0.00	1.18	0.39
Endothelial Cells - Artery, donor1	11264-116G4	269.35	3.78	2.04	0.29	0.58	1.16	0.58
Endothelial Cells - Artery, donor2	11341-117F9	280.69	5.41	6.12	1.18	1.65	1.18	0.47
Endothelial Cells - Artery, donor3	11413-118E9	354.83	6.49	2.63	1.93	1.40	1.05	1.23
Endothelial Cells - Lymphatic, donor1	11236-116D3	11.08	0.22	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	61.77	0.30	0.30	0.30	0.00	0.00	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	29.04	0.28	0.00	0.28	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	167.88	0.89	0.89	0.30	0.59	0.30	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	119.75	0.52	1.56	0.52	0.00	1.56	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	45.80	0.85	0.43	0.43	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	399.72	2.80	2.40	1.60	0.00	0.40	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	399.91	13.63	9.43	3.67	2.62	0.00	2.10
Endothelial Cells - Umbilical vein, donor1	11243-116E1	10.31	0.12	0.00	0.12	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	2.61	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	3.42	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor1	11267-116G7	60.29	0.00	1.14	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	308.74	4.19	2.10	1.40	1.40	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	99.54	0.63	0.94	0.16	0.47	0.00	0.16
Eosinophils, donor1	12244-129H3	1280.74	15.25	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	820.18	3.30	6.60	0.00	1.65	1.65	1.65
Eosinophils, donor3	12246-129H5	759.73	3.57	7.13	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	501.11	3.18	1.47	2.20	0.24	0.73	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	374.43	8.32	6.24	2.08	4.16	2.08	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	650.75	0.00	0.00	16.27	0.00	16.27	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	379.32	2.87	4.52	2.87	0.41	1.23	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	482.62	23.21	15.33	8.21	10.07	6.35	9.20
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	188.51	6.61	3.36	2.71	1.41	1.30	0.76
Fibroblast - Aortic Adventitial, donor1	11245-116E3	645.57	8.37	10.92	2.67	1.70	1.94	1.94
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	1038.82	6.14	5.05	2.59	0.82	1.50	0.96
Fibroblast - Aortic Adventitial, donor2	11326-117E3	401.52	11.60	7.38	4.01	2.00	2.43	1.69
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	2162.73	43.48	28.46	8.96	6.59	8.17	3.95
Fibroblast - Aortic Adventitial, donor3	11401-118D6	674.37	13.95	8.97	3.32	1.99	1.99	3.65
Fibroblast - Cardiac, donor1	11268-116G8	321.17	8.17	3.18	1.81	3.63	2.72	1.81
Fibroblast - Cardiac, donor2	11345-117G4	356.99	4.55	1.52	0.76	2.27	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	387.98	6.94	5.20	1.58	1.89	1.73	1.10
Fibroblast - Cardiac, donor4	11452-119A3	355.24	0.30	1.82	0.91	0.30	0.00	0.91
Fibroblast - Cardiac, donor5	11456-119A7	271.70	5.20	3.55	1.65	1.14	1.52	1.02
Fibroblast - Cardiac, donor6	11460-119B2	252.71	3.34	3.03	0.76	1.06	0.76	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	305.90	1.61	1.21	0.27	0.13	0.27	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	159.63	1.29	0.00	0.43	1.29	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	480.45	13.18	7.32	8.79	2.93	4.39	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	725.13	3.00	1.61	0.69	0.92	0.69	0.92
Fibroblast - Conjunctival, donor3	11692-122I9	1010.84	6.61	7.46	2.54	1.87	0.51	0.85
Fibroblast - Dermal, donor1	11269-116G9	507.60	8.92	5.63	2.11	1.88	1.17	1.64
Fibroblast - Dermal, donor2	11346-117G5	493.38	2.83	3.30	0.47	0.47	0.00	0.47
Fibroblast - Dermal, donor3	11418-118F5	591.74	9.31	5.92	3.14	2.78	0.97	1.57
Fibroblast - Dermal, donor4	11450-119A1	449.24	12.89	6.78	1.47	2.71	1.24	1.36
Fibroblast - Dermal, donor5	11454-119A5	467.53	8.72	5.06	1.40	2.62	0.87	0.70
Fibroblast - Dermal, donor6	11458-119A9	500.43	8.93	5.85	2.11	3.41	1.79	1.30
Fibroblast - Gingival, donor1	11237-116D4	562.43	3.12	3.33	1.04	1.04	0.62	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	1526.15	25.41	17.29	5.50	3.67	2.36	5.24
Fibroblast - Gingival, donor2	11318-117D4	369.79	11.20	4.88	2.77	2.11	1.32	0.79
Fibroblast - Gingival, donor3	11394-118C8	857.42	7.25	8.03	1.84	2.90	2.13	1.64
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	698.14	7.27	10.39	5.19	1.04	1.04	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	533.02	20.26	7.93	4.41	3.00	1.59	1.59
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	1781.74	18.71	10.45	5.61	7.64	3.90	2.49
Fibroblast - Gingival, donor6 (control)	11922-125H5	1067.35	18.66	10.82	5.14	2.70	2.84	1.49
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	843.38	0.71	2.82	2.12	0.00	2.12	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	1014.35	13.02	7.75	5.41	3.07	3.80	2.63
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	1049.78	13.91	8.73	3.55	3.41	3.68	1.91
Fibroblast - Gingival, donor8 (control)	11926-125H9	1041.54	18.10	10.97	5.27	3.84	3.40	2.41
Fibroblast - Gingival, donor9 (control)	11927-125I1	925.04	16.43	14.23	4.55	3.08	2.93	3.96
Fibroblast - Lung, donor1	11270-116H1	727.25	6.80	6.80	1.36	0.00	0.00	4.08
Fibroblast - Lung, donor2	11347-117G6	614.77	8.95	2.98	5.97	2.98	1.49	1.49
Fibroblast - Lung, donor3	11419-118F6	623.19	12.66	7.18	2.32	2.11	1.90	1.90
Fibroblast - Lymphatic, donor1	11506-119G3	2731.48	6.66	5.00	2.50	1.67	0.83	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	639.17	6.99	2.80	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	436.33	6.72	2.80	1.40	1.12	0.56	0.56
Fibroblast - Mammary, donor1	11540-120B1	1394.91	3.25	4.47	0.41	2.03	0.00	0.81
Fibroblast - Mammary, donor2	11620-122A9	531.23	19.97	11.98	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	488.41	5.96	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	320.44	3.30	2.33	0.78	0.58	0.58	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	398.32	12.13	7.43	1.82	4.10	1.82	1.06
Fibroblast - Periodontal Ligament, donor3	11395-118C9	1069.43	2.45	2.14	0.92	0.31	0.92	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	588.08	6.11	4.96	1.53	1.91	1.53	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	384.20	14.31	8.91	3.78	3.24	1.62	1.35
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	404.17	6.96	4.75	1.62	1.74	1.04	1.28
Fibroblast - Pulmonary Artery, donor1	11250-116E8	200.95	3.09	0.99	1.11	0.88	0.33	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	3206.35	9.14	6.91	4.27	4.27	1.63	2.03
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	575.32	7.35	4.68	0.00	0.67	2.67	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	420.66	2.77	0.79	1.58	1.98	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	3275.18	41.87	16.87	11.71	7.54	12.70	2.78
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	668.56	5.33	4.62	1.95	0.53	0.00	1.24
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	924.72	10.25	5.91	2.37	1.58	0.99	1.18
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	5040.52	47.54	23.77	14.14	10.83	13.84	8.12
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	1833.99	17.70	20.29	5.18	5.07	2.37	1.84
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	1551.35	14.93	8.10	4.56	4.56	3.80	1.77
Fibroblast - skin normal, donor1	11553-120C5	1078.49	9.02	10.01	2.95	1.15	2.46	2.46
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	5241.46	26.47	23.46	12.83	8.02	4.81	4.01
Fibroblast - skin normal, donor2	11561-120D4	1465.94	16.17	15.87	3.62	3.82	2.51	2.71
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	2204.52	20.85	10.28	8.46	4.53	5.44	1.81
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	927.30	5.88	7.70	2.15	2.07	1.74	0.66
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	2443.05	30.43	34.36	9.74	7.35	4.44	4.27
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	3688.95	46.31	23.98	9.20	7.55	12.48	5.25
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	1809.59	17.15	15.87	5.43	4.79	2.88	2.56
Fibroblast - skin walker warburg, donor1	11554-120C6	1110.09	11.13	5.40	2.53	2.53	2.02	1.35
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	925.55	28.38	22.11	6.59	11.45	6.43	3.61
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	421.04	44.32	132.96	110.80	0.00	22.16	44.32
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	1165.24	46.19	17.43	19.17	6.97	6.10	2.61
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	1261.00	7.80	9.71	10.23	1.39	2.43	1.39
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	1446.94	12.23	9.63	10.93	1.30	2.60	3.12
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	1912.26	9.96	15.59	6.90	2.56	2.30	2.04
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	10.72	0.77	1.53	0.00	0.00	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	16.59	0.00	1.28	0.64	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	12.84	0.86	0.86	0.29	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	1.10	0.00	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	1.37	0.23	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	9.11	0.40	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	1.59	0.26	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	1.63	0.00	0.00	0.00	0.00	0.33	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	10.17	0.00	0.44	0.44	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	30.67	0.42	0.71	0.14	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	55.29	0.99	0.74	0.49	0.25	0.00	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	37.88	0.81	0.27	0.27	0.00	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	453.57	10.04	6.44	1.98	1.49	1.49	1.73
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	446.42	9.69	3.88	2.35	1.52	1.11	1.52
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	285.23	7.52	3.86	2.03	1.63	1.63	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	355.50	4.11	3.19	1.37	2.28	0.46	1.14
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	517.94	12.83	5.61	1.99	2.74	1.87	1.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	474.97	6.34	4.81	2.40	1.09	1.97	1.53
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	215.11	1.48	1.77	0.59	0.89	1.18	1.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	206.33	6.68	2.86	1.59	0.95	0.32	0.95
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	202.64	1.34	1.79	0.45	0.89	0.45	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	227.64	6.25	1.81	1.41	1.21	0.60	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	197.63	4.75	2.71	1.36	1.53	0.68	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	266.02	2.13	3.55	0.89	0.44	0.53	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	720.17	5.62	6.24	1.66	0.83	0.73	0.73
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	658.00	3.93	5.81	1.54	0.68	1.02	0.85
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	346.90	4.43	3.87	1.11	0.89	1.33	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	201.09	1.33	1.58	0.50	0.50	0.33	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	209.29	1.23	1.02	1.02	0.61	0.20	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	352.78	3.92	3.71	1.44	1.44	1.24	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	323.40	5.30	2.31	1.04	1.27	0.92	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	244.14	5.34	2.50	0.67	1.33	0.67	1.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	534.32	8.82	3.97	0.44	2.65	1.32	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	584.34	13.28	8.98	2.34	3.81	2.58	2.09
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	152.04	0.65	1.62	0.00	1.62	0.81	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	673.82	10.26	7.06	3.21	3.85	1.60	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	516.88	11.09	5.97	1.42	1.99	1.14	0.85
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	380.26	4.11	3.16	0.95	1.58	0.95	0.79
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	667.17	18.25	13.68	2.43	4.26	3.34	1.82
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	558.86	9.83	6.79	1.99	1.78	1.46	1.05
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	325.16	2.63	4.39	1.10	1.10	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	513.12	7.57	4.77	1.40	1.68	1.96	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	670.24	13.98	10.46	1.76	1.48	1.94	1.02
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	405.92	8.02	3.74	2.41	3.21	1.60	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	614.93	8.26	4.13	2.91	1.38	1.84	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	464.65	9.84	6.09	0.78	1.81	1.04	1.04
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	354.29	4.61	2.71	2.17	1.63	0.27	1.08
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	634.91	10.51	5.53	2.95	3.69	1.66	1.29
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	684.26	12.06	6.36	1.97	3.95	3.07	1.32
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	891.58	3.97	1.98	0.00	0.00	0.00	3.97
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	436.10	5.28	2.24	0.40	1.32	1.71	0.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	465.05	5.65	5.04	2.22	3.23	0.81	1.82
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	1561.56	4.83	4.32	2.29	1.27	0.76	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	22.29	0.00	0.20	0.00	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	12.63	0.46	0.00	0.00	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	13.09	0.20	0.00	0.00	0.20	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	8.14	0.31	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	5.37	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	5.53	0.46	0.00	0.46	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	2.47	2.47	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	10.06	0.00	0.39	0.39	0.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	9.63	0.00	1.60	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	8.69	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	5.53	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	9.88	0.41	0.41	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	13.33	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	8.67	0.56	0.56	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	9.15	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	5.03	1.68	0.00	0.00	0.00	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	11.13	0.00	0.32	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	9.17	0.34	0.34	0.34	0.00	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	10.44	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	14.89	0.57	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	11.84	0.30	0.00	0.30	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	8.47	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	13.25	0.83	0.83	0.00	0.41	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	11.97	0.00	0.69	0.23	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	5.27	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	17.68	1.15	0.77	0.00	0.38	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	20.86	0.98	0.65	0.00	0.00	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	28.09	1.34	0.00	1.34	0.00	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	39.30	1.16	0.39	0.00	0.00	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	26.02	0.00	0.34	0.00	0.34	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	4.97	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	42.94	2.36	1.42	0.47	0.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	42.24	3.02	0.60	0.60	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	36.62	1.02	0.51	0.51	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	40.68	1.20	2.39	0.40	0.40	0.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	46.87	0.99	0.99	0.99	0.49	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	23.61	1.18	1.18	1.18	2.36	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	63.60	2.92	1.75	1.17	0.00	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	37.74	0.88	0.00	0.88	0.44	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	34.76	0.00	0.85	0.85	0.85	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	29.85	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	57.26	2.43	0.00	1.46	0.00	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	528.42	9.13	5.71	2.28	4.57	1.14	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	642.02	14.55	9.56	4.99	3.74	2.91	2.91
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	1046.87	7.87	3.37	4.50	3.37	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	492.87	7.29	4.44	1.59	2.85	2.22	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	550.58	11.28	4.18	1.67	2.51	2.92	2.51
Hep-2 cells mock treated, biol_rep1	11898-125E8	341.16	5.69	5.45	1.39	2.44	1.74	0.81
Hep-2 cells mock treated, biol_rep2	11899-125E9	339.46	8.44	3.21	1.18	2.87	1.35	1.52
Hep-2 cells mock treated, biol_rep3	11900-125F1	345.12	7.28	2.50	1.37	2.50	1.14	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	354.71	11.15	4.48	2.62	2.40	1.64	1.09
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	356.97	5.16	3.01	1.07	2.15	0.86	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	328.95	6.24	2.15	1.08	1.51	1.08	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	370.62	4.48	4.23	2.24	1.99	1.25	0.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	358.20	6.52	3.60	1.37	2.57	0.86	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	343.76	6.73	2.88	1.60	1.60	1.60	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	33.58	0.56	0.00	0.00	0.56	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	275.26	2.16	1.73	2.60	2.60	1.30	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	124.26	13.22	5.29	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	122.04	1.41	0.00	0.35	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	103.89	2.18	0.73	0.73	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	227.81	5.25	1.22	0.70	0.87	0.52	0.70
Hepatocyte, donor1	11523-119I2	8.47	0.00	0.00	0.00	0.00	1.21	0.00
Hepatocyte, donor2	11603-120I1	61.41	3.23	0.00	1.08	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	42.33	0.00	0.00	0.00	0.00	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	34.59	0.00	1.31	0.65	0.65	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	63.27	1.05	0.87	0.35	0.17	0.87	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	494.36	3.98	2.74	1.10	1.23	0.55	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	12.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	5.54	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	15.02	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	2.56	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	0.00	0.00	0.00	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	9.75	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	5.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	2.65	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	16.63	1.11	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	4.41	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	10.83	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	6.46	0.00	0.00	0.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	16.10	3.22	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	8.15	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	15.95	0.00	0.42	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	11.25	1.61	1.61	0.00	0.00	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	11.08	0.00	0.92	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	8.50	0.47	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	9.07	0.91	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	5.38	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	10.16	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	13.39	0.00	0.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	5.47	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	13.57	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	3.32	0.00	3.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	7.10	0.31	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	3.51	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	8.34	0.70	0.00	0.00	0.00	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	11.07	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	14.82	0.00	0.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	4.50	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	12.80	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	2.77	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	11.97	0.00	0.00	0.00	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	4.23	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	1573.15	9.63	14.20	12.73	3.35	2.94	3.18
Keratinocyte - epidermal, donor2	11349-117G8	378.91	1.17	1.76	4.69	1.17	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	684.84	11.74	4.16	9.18	1.61	2.84	1.61
Keratinocyte - oral, donor1	11251-116E9	1001.45	10.33	6.13	9.65	2.72	2.27	1.02
Keratocytes, donor1	11527-119I6	746.46	3.09	3.78	1.72	1.38	0.69	1.03
Keratocytes, donor2	11607-120I5	530.83	9.37	3.52	1.17	0.00	0.00	2.34
Keratocytes, donor3	11688-122I5	288.49	2.37	1.78	0.59	1.19	0.40	0.79
Krukenberg tumor cell line:HSKTC	10687-109F3	424.20	2.20	0.00	2.20	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	379.72	6.47	4.31	5.39	2.16	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	528.57	2.77	2.08	1.73	0.58	0.69	0.46
Lens Epithelial Cells, donor3	11690-122I7	345.11	0.61	0.50	0.20	0.40	0.30	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	61.42	0.59	0.59	0.12	0.47	0.36	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	33.77	1.12	0.00	0.28	0.00	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	17.16	0.16	0.79	0.16	0.16	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	54.85	0.54	1.61	0.00	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	44.12	1.26	0.32	0.63	0.00	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	14.77	0.43	0.11	0.11	0.11	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	52.53	0.82	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	27.05	0.25	0.51	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	12.95	0.28	0.42	0.00	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	54.19	1.19	0.00	0.79	1.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	29.66	0.19	0.00	0.00	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	11.85	0.00	0.00	0.00	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	58.19	0.35	0.00	0.00	0.35	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	36.02	0.72	0.24	0.48	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	16.21	0.14	0.27	0.00	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	50.81	0.62	0.92	0.31	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	31.49	0.00	0.31	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	15.74	0.18	0.00	0.00	0.00	0.00	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	47.72	1.65	0.33	0.00	0.66	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	38.66	0.29	0.00	0.00	0.59	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	14.44	0.00	0.00	0.00	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	59.65	0.97	0.48	0.48	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	36.09	0.00	0.54	0.00	0.54	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	14.99	0.00	0.15	0.00	0.00	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	59.10	0.00	1.56	0.52	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	36.85	0.00	0.63	0.21	0.00	0.00	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	15.79	0.30	0.15	0.30	0.15	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	58.47	0.69	0.69	0.69	0.69	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	32.55	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	12.09	0.32	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	57.18	1.94	0.00	0.48	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	32.42	0.33	0.00	0.00	0.00	0.66	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	14.25	0.12	0.25	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	55.90	0.74	0.37	0.74	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	33.11	0.74	0.49	0.49	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	11.41	0.00	0.27	0.00	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	53.07	0.32	1.29	0.32	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	38.95	0.61	0.61	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	9.80	0.28	0.00	0.00	0.00	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	46.58	0.71	1.07	0.71	0.71	0.00	1.07
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	42.66	0.48	0.97	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	11.98	0.47	0.47	0.16	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	52.64	0.72	0.00	0.36	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	37.57	0.65	0.98	0.00	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	8.00	0.24	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	78.95	0.74	0.99	0.37	0.37	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	31.25	0.77	0.00	0.00	0.00	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	11.34	0.30	0.00	0.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	92.91	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	70.58	0.00	0.77	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	74.96	0.74	0.00	0.74	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	88.86	2.54	0.85	1.27	0.85	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	85.10	2.11	1.41	0.70	0.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	93.40	0.93	0.00	0.93	0.00	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	71.11	4.64	4.64	0.52	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	57.09	2.38	0.00	2.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	91.38	0.90	0.68	0.68	0.23	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	82.30	3.49	2.04	0.87	0.87	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	71.58	1.80	1.80	1.80	0.45	0.90	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	107.98	1.49	0.68	0.14	0.54	0.27	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	81.14	1.03	2.05	1.03	0.51	1.03	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	87.86	2.47	1.06	1.76	0.35	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	85.95	0.00	0.00	1.33	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	99.33	3.06	1.02	0.51	1.53	1.02	2.04
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	92.05	2.93	0.53	1.33	1.60	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	83.70	1.70	0.57	1.13	1.32	0.94	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	88.97	3.07	3.07	0.61	0.61	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	87.25	6.52	0.82	0.82	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	86.42	4.58	1.04	1.04	0.62	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	100.61	5.04	1.12	3.64	0.28	0.56	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	114.37	0.00	1.03	1.03	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	99.57	6.39	4.35	2.90	1.45	0.87	1.16
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	86.39	2.69	1.79	1.49	1.20	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	77.46	1.66	1.11	1.66	0.00	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	115.59	4.95	1.77	1.41	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	92.56	4.06	2.58	0.74	1.11	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	82.89	2.30	0.00	1.15	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	95.94	1.54	0.77	1.54	1.92	0.38	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	84.35	8.49	2.83	4.53	2.26	1.70	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	100.92	0.82	1.64	1.64	0.82	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	108.90	5.42	1.81	0.45	1.36	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	96.95	4.31	1.44	2.15	1.44	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	126.97	0.00	0.75	1.49	2.24	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	106.65	6.69	2.60	1.86	1.11	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	98.21	2.15	2.15	0.43	0.43	0.86	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	111.32	1.71	0.00	2.57	0.00	1.71	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	105.62	5.66	2.33	1.67	1.00	0.67	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	144.19	5.43	0.60	3.02	1.21	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	93.85	6.40	0.71	0.71	0.00	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	108.61	3.09	1.03	0.34	1.37	0.69	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	108.42	4.29	2.15	2.68	1.07	1.07	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	97.64	4.04	1.35	2.69	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	107.05	3.70	2.96	2.59	1.48	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	102.34	1.16	2.33	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	102.60	1.06	1.06	1.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	109.24	2.40	2.00	1.20	0.80	0.40	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	92.31	2.18	1.45	0.73	0.73	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	92.75	1.53	0.77	1.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	94.71	2.96	1.48	0.99	1.97	0.00	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	89.39	2.82	1.88	0.00	2.82	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	89.50	1.51	1.51	1.01	0.00	1.01	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	88.77	2.70	1.80	1.80	0.00	1.35	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	82.61	1.72	3.44	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	101.09	3.56	0.89	3.12	0.45	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	96.58	3.13	1.56	1.56	0.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	79.83	1.98	0.66	0.66	1.98	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	93.41	1.56	0.52	0.00	1.04	0.52	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	122.96	3.50	3.94	1.75	0.00	0.44	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	112.38	1.68	0.00	1.68	1.68	1.68	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	100.69	2.21	0.88	1.32	0.00	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	104.91	3.09	1.16	1.54	0.77	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	103.30	4.05	2.53	2.03	1.52	1.01	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	99.01	2.40	0.48	0.00	0.48	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	101.77	2.78	2.78	1.19	1.99	1.19	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	113.63	4.86	0.61	0.61	3.65	1.82	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	113.44	4.15	1.38	0.69	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	111.72	3.80	2.66	3.04	0.76	0.38	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	115.16	9.30	3.61	2.07	2.07	0.52	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	137.86	4.84	1.21	1.21	0.60	1.21	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	122.32	5.07	2.22	0.95	0.95	0.32	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	124.21	2.13	0.53	1.07	1.07	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	148.84	2.30	1.72	2.30	0.57	0.57	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	127.02	3.09	3.60	6.17	1.03	2.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	157.03	6.37	2.12	3.54	2.12	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	164.00	6.81	0.00	1.70	0.57	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	118.57	2.91	1.25	0.83	2.08	0.83	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	151.13	6.26	3.92	3.13	1.57	0.78	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	148.65	1.25	0.84	2.51	0.00	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	137.07	5.58	2.32	1.39	0.93	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	123.77	6.69	3.35	3.35	0.67	1.34	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	167.34	5.35	3.21	2.67	0.53	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	124.87	5.25	3.23	0.81	0.81	1.62	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	141.34	0.00	3.67	2.75	1.84	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	211.61	6.22	6.22	5.33	2.67	1.78	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	177.23	3.42	2.28	1.14	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	157.21	3.83	3.07	0.00	1.53	1.53	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	239.66	7.66	1.09	2.74	2.19	1.09	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	187.53	3.56	1.34	2.23	0.89	1.34	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	238.90	2.60	1.56	1.04	0.26	0.52	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	241.37	3.32	1.99	1.99	1.33	0.66	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	201.63	8.31	6.24	10.39	0.00	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	764.66	6.38	6.38	2.73	0.68	0.23	0.91
Macrophage - monocyte derived, donor2	11313-117C8	1395.39	7.71	8.81	5.32	2.02	1.28	0.92
Macrophage - monocyte derived, donor3	11389-118C3	1073.69	14.03	8.39	4.85	4.85	1.70	1.97
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	560.76	2.12	0.53	2.66	0.00	0.53	0.53
Mallassez-derived cells, donor2	11929-125I3	1295.19	12.83	11.25	9.03	4.44	2.22	1.43
Mallassez-derived cells, donor3	11930-125I4	1137.89	9.73	8.90	5.42	3.20	2.08	1.25
Mammary Epithelial Cell, donor1	11273-116H4	1451.01	10.86	5.28	14.15	1.49	1.59	1.89
Mammary Epithelial Cell, donor2	11350-117G9	1317.45	9.84	5.79	15.06	3.47	2.32	0.87
Mammary Epithelial Cell, donor3	11422-118F9	915.40	9.73	4.99	7.98	2.00	2.74	0.25
Mast cell - stimulated, donor1	11487-119E2	6799.70	29.15	16.95	6.78	6.10	2.71	6.10
Mast cell, donor1	11563-120D6	1155.59	8.00	11.46	5.52	1.41	4.00	3.35
Mast cell, donor2	11565-120D8	5809.46	58.25	107.58	16.64	17.24	36.26	17.83
Mast cell, donor3	11566-120D9	4888.35	38.72	79.92	17.56	11.71	30.84	14.41
Mast cell, donor4	11567-120E1	5016.57	45.03	87.58	17.02	8.16	28.90	12.06
Mast cell, expanded and stimulated, donor5	11940-126A5	2359.25	22.07	22.18	5.99	7.43	5.54	5.32
Mast cell, expanded and stimulated, donor8	11942-126A7	1960.59	23.35	22.18	8.17	7.59	3.50	8.17
Mast cell, expanded, donor5	11939-126A4	1296.93	16.75	15.60	6.88	3.79	3.10	3.33
Mast cell, expanded, donor8	11941-126A6	1831.17	22.59	30.29	8.70	5.02	6.36	5.52
Melanocyte - dark, donor1	11502-119F8	4.78	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - dark, donor2	11582-120F7	93.10	1.38	0.69	1.04	0.35	0.35	0.35
Melanocyte - dark, donor3	11663-122F7	1050.32	6.95	4.35	3.33	1.67	0.43	0.36
Melanocyte - light, donor1	11274-116H5	1241.89	7.76	16.22	2.12	1.88	1.88	2.35
Melanocyte - light, donor2	11351-117H1	1021.65	9.55	17.06	5.46	4.09	4.78	2.05
Melanocyte - light, donor3	11423-118G1	520.33	4.34	4.34	4.34	1.73	1.73	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	975.13	25.20	14.06	6.25	4.17	3.02	1.46
Melanocyte, donor2 (MC+2)	12739-135I3	916.02	14.79	8.07	4.84	2.96	3.23	1.61
Melanocyte, donor3 (MC+3)	12837-137B2	1423.65	21.16	14.46	4.82	7.77	3.75	4.55
Meningeal Cells, donor1	11493-119E8	776.61	1.61	3.10	0.99	0.62	0.50	0.62
Meningeal Cells, donor2	11573-120E7	162.41	0.88	1.76	0.88	0.44	0.00	0.00
Meningeal Cells, donor3	11654-122E7	603.19	4.81	2.77	1.39	1.22	0.90	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	360.44	3.42	2.57	0.86	1.14	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	781.41	6.84	7.55	2.11	1.71	0.60	1.11
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	343.00	1.31	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	345.35	3.92	1.31	0.00	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	517.39	7.89	5.02	5.74	2.87	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	745.64	8.47	11.65	1.27	1.91	0.64	1.48
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	1063.10	22.12	13.07	6.03	6.53	4.02	4.52
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	254.25	1.54	0.88	0.22	0.22	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	218.45	4.38	0.73	0.73	0.00	1.46	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	387.52	5.73	2.86	1.02	1.43	1.02	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	531.87	2.63	1.80	0.42	1.11	1.25	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	126.39	0.00	0.37	0.00	0.00	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	451.17	4.08	2.50	1.84	0.79	0.53	1.18
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	61.72	0.89	0.00	0.30	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	74.74	0.00	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	245.27	1.28	1.28	1.28	1.92	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	545.49	6.38	3.19	0.71	0.35	0.71	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	338.68	3.13	2.50	1.25	0.94	0.31	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	464.44	5.81	1.45	4.35	3.63	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	859.43	9.28	10.61	2.39	0.80	0.80	1.59
Mesothelial Cells, donor2	12156-128G5	727.18	5.51	6.51	2.50	3.50	1.50	0.50
Mesothelial Cells, donor3	11402-118D7	593.36	8.96	7.23	3.32	2.46	1.59	1.45
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	618.45	1.35	0.00	0.00	0.00	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	571.60	10.59	10.84	1.23	3.20	0.99	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	523.25	5.59	6.18	0.59	1.47	0.29	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	528.93	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	394.25	3.72	4.34	1.55	0.93	0.93	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	456.56	4.98	3.73	1.45	1.45	1.24	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	465.53	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	695.98	8.26	7.76	1.50	5.51	1.75	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	635.85	1.86	2.79	3.26	0.47	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	506.12	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	626.51	5.89	4.47	2.03	2.64	1.63	1.02
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	628.00	4.36	1.98	3.96	0.00	1.19	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	581.50	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	804.41	16.81	8.85	1.77	4.42	2.65	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	583.58	6.84	3.42	4.18	1.52	0.76	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	940.87	2.63	0.00	2.63	1.32	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	1009.55	16.98	14.86	4.67	6.37	3.40	1.27
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	611.43	2.76	3.68	1.84	0.00	0.92	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	1137.08	9.24	11.03	4.77	5.07	2.38	0.89
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	561.69	3.35	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	1018.48	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	1208.10	18.82	14.30	5.52	5.77	4.77	2.76
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	938.79	7.84	6.18	3.09	1.19	2.38	1.43
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	1577.38	1.66	1.66	3.32	0.55	0.00	2.21
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	1513.64	26.48	17.50	8.29	8.52	5.99	2.99
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	1266.87	9.47	9.04	3.16	2.73	2.73	1.47
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	2023.40	23.03	19.98	5.50	4.08	3.67	2.04
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	1259.56	15.88	15.23	9.01	5.15	4.08	2.36
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	1516.02	14.00	7.56	3.56	3.11	2.67	1.11
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	1238.22	0.00	0.00	0.00	0.00	0.00	10.32
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	1972.47	19.27	13.58	6.35	9.64	4.82	3.50
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	1533.04	7.60	3.04	3.55	2.03	1.01	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1835.95	8.28	1.66	6.63	1.66	0.00	4.97
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	2390.41	32.62	24.73	10.33	14.95	5.98	4.08
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	1918.30	14.70	7.94	3.82	4.12	0.59	1.18
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	2096.69	8.72	9.81	16.35	3.27	2.18	4.36
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	2137.03	38.44	19.70	12.01	15.86	6.25	6.73
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	1908.29	37.22	15.21	13.61	4.80	5.20	7.60
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	2001.98	1.37	1.37	4.11	0.00	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	2727.15	42.55	27.53	18.52	13.52	6.01	4.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	1859.35	53.89	0.00	26.95	0.00	26.95	26.95
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	1433.07	0.00	0.00	0.00	2.04	0.00	4.08
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	2980.93	37.22	22.77	17.95	15.77	7.88	7.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	1250.44	3.31	0.00	0.00	1.10	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	2061.41	5.12	3.20	1.92	0.00	1.28	1.28
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	3363.27	46.86	36.20	14.63	16.86	10.16	5.95
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	1654.15	5.57	2.78	1.39	3.48	0.70	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2033.08	11.05	0.00	0.00	4.42	2.21	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	3251.58	55.73	30.09	17.09	16.75	8.89	7.18
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	1602.11	3.94	3.94	3.94	0.44	0.44	1.31
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	1953.03	3.55	2.84	1.78	1.78	0.71	1.42
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	3286.66	44.05	35.35	14.87	15.15	14.59	11.50
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	1550.71	9.56	5.40	4.99	1.25	2.49	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	1606.63	5.83	1.75	0.00	1.75	0.58	1.75
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	2802.77	38.01	29.26	11.76	11.76	8.45	7.24
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	1586.09	22.54	13.36	5.84	6.26	7.51	1.67
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	1386.01	7.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	2385.54	82.20	41.56	14.78	31.40	5.54	7.39
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	1784.75	20.49	16.50	6.83	3.98	3.41	3.41
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	2089.30	12.99	15.06	3.87	6.22	2.07	2.76
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	2263.14	35.50	30.06	10.63	15.03	6.74	5.96
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	1465.81	9.87	9.01	4.29	4.29	1.72	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	1192.89	1.27	3.18	0.64	0.64	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	2051.04	20.02	13.88	6.14	7.74	2.67	3.74
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	2064.77	18.86	15.57	4.49	4.79	3.89	2.39
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	1726.26	16.53	11.58	4.10	3.81	1.55	2.26
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	2048.36	31.85	19.75	8.28	8.92	11.78	4.14
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	1383.61	11.72	8.85	3.10	5.09	2.65	0.88
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	1479.64	4.17	4.17	1.90	1.14	1.14	1.52
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	2046.42	18.75	22.44	5.97	4.83	6.82	5.40
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	1510.46	22.86	14.26	5.41	2.95	4.67	2.46
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	1380.89	1.96	1.30	5.21	0.65	0.65	1.96
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	2094.65	29.40	23.82	7.06	14.11	6.47	3.53
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	1729.96	17.30	14.13	4.90	5.77	3.75	1.73
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	3540.73	31.32	35.03	6.59	10.72	4.95	4.12
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	2090.73	14.00	13.10	4.47	4.47	2.68	2.98
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	327.72	7.53	0.00	0.00	0.00	3.77	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	361.80	16.04	3.56	1.78	1.78	1.78	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	487.60	11.17	5.26	3.61	3.94	2.63	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	454.44	13.68	5.26	7.36	1.05	1.05	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	424.83	4.55	2.77	1.78	0.79	0.59	1.19
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	697.56	6.52	2.79	3.73	0.93	4.66	2.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	423.97	10.14	5.26	2.25	2.25	1.13	1.88
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	433.61	6.92	3.20	3.20	1.86	1.60	1.07
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	422.88	2.83	2.26	1.36	0.68	1.13	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	390.46	4.42	8.10	3.68	2.95	1.47	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	387.31	10.63	6.60	2.56	1.47	2.93	1.83
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	584.90	42.00	15.56	14.00	4.67	7.78	6.22
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	357.54	3.21	1.60	2.14	1.60	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	397.98	30.91	3.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	450.43	11.11	2.02	4.04	1.01	2.02	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	451.58	5.90	6.75	3.37	1.26	3.79	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	222.00	2.72	0.00	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	459.68	3.18	3.18	1.27	1.91	1.27	1.27
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	379.00	1.62	1.62	1.62	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	181.25	3.02	4.53	4.53	1.51	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	365.45	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	884.12	3.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	589.31	4.75	9.50	0.00	4.75	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	213.33	12.55	0.00	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	488.82	3.88	3.45	1.72	1.72	0.86	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	208.52	3.14	3.14	1.05	0.52	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	899.77	11.35	8.68	4.00	8.01	2.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	699.93	7.51	2.92	2.92	3.76	1.67	2.09
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	710.75	21.68	16.16	3.04	7.04	3.99	3.04
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	1222.42	14.36	4.79	0.00	0.00	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	598.35	14.96	3.40	1.36	5.44	3.40	5.44
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	518.21	16.54	9.19	1.84	3.68	9.19	7.35
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	499.31	10.88	8.37	2.93	4.60	3.35	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	713.12	14.88	7.21	2.32	2.79	2.32	2.56
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	583.15	10.27	6.76	2.16	4.32	3.24	2.16
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	702.61	7.78	4.20	1.26	2.10	2.52	1.89
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	656.95	44.54	11.13	22.27	22.27	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	856.71	17.87	10.92	6.45	6.95	5.96	3.97
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	424.14	8.66	5.68	1.35	2.17	2.71	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	613.40	16.09	10.43	4.53	4.99	3.40	2.72
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	395.68	7.02	3.27	1.31	3.27	1.80	1.14
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	533.46	21.32	8.75	3.83	4.74	2.92	2.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	754.81	18.03	12.73	5.30	5.83	4.77	5.30
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	687.95	15.01	10.21	3.00	6.00	4.80	4.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	456.82	14.11	11.16	2.30	4.59	1.97	1.64
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	443.64	11.71	5.20	3.09	3.58	1.63	0.65
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	517.68	8.29	7.23	0.88	2.29	1.41	0.88
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	455.69	10.55	7.74	2.11	5.63	2.11	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	621.53	12.41	8.73	5.98	3.22	2.30	1.84
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	323.27	8.68	4.50	1.61	2.57	2.57	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	616.32	21.04	22.07	5.86	6.21	6.21	3.45
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	596.71	12.64	7.59	0.00	5.06	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	403.91	2.01	2.01	1.11	1.78	0.22	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	374.70	12.28	7.62	2.54	3.39	3.39	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	558.25	12.58	7.83	1.66	4.98	3.56	1.90
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	250.68	5.58	6.01	1.72	3.43	1.29	1.72
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	812.50	9.03	0.00	0.00	0.00	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	340.89	8.33	3.33	1.67	2.67	2.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	239.86	2.71	1.35	0.90	1.35	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	193.24	5.56	3.97	1.98	0.79	1.19	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	654.70	23.22	10.22	3.71	7.43	1.86	3.71
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	224.75	7.19	3.41	1.14	2.27	1.51	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	286.45	7.82	5.21	0.98	2.28	0.33	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	389.59	2.18	3.49	0.44	2.61	0.00	1.31
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	231.12	2.71	3.17	0.90	0.45	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	225.77	7.94	2.65	2.65	0.88	0.88	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	632.27	22.60	11.97	3.99	5.32	7.98	1.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	280.26	4.96	6.45	1.49	1.98	2.48	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	259.17	4.98	2.30	1.15	1.15	1.15	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	421.91	8.77	6.05	1.21	0.60	2.12	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	243.79	3.09	3.09	0.44	0.88	1.11	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	194.49	4.74	6.10	2.71	0.00	1.36	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	459.86	25.55	10.22	0.00	0.00	5.11	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	260.33	4.27	2.44	2.44	0.61	1.83	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	186.01	2.83	1.26	0.94	1.57	0.00	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	402.23	4.84	3.93	1.51	3.03	2.72	1.82
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	170.09	13.45	6.33	0.79	1.58	1.58	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	324.22	7.94	4.53	5.67	6.80	2.27	3.40
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	364.17	5.06	0.00	5.06	10.12	10.12	15.17
Myoblast, donor1	11241-116D8	606.86	9.81	6.21	3.85	2.24	1.49	0.87
Myoblast, donor2	11322-117D8	638.46	22.25	14.58	6.52	6.52	3.64	3.26
Myoblast, donor3	11398-118D3	832.07	4.04	5.21	3.20	1.01	0.67	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	582.27	3.94	2.92	1.75	1.02	1.02	1.02
Natural Killer Cells, donor1	11230-116C6	1313.10	8.30	6.77	4.31	0.62	1.23	1.85
Natural Killer Cells, donor2	11311-117C6	1191.75	27.74	18.09	5.73	5.43	4.82	0.90
Natural Killer Cells, donor3	11387-118C1	1054.26	11.78	5.71	5.15	2.58	0.92	1.66
Neural stem cells, donor1	11275-116H6	1838.29	28.31	21.05	9.07	4.36	1.81	2.90
Neural stem cells, donor2	11352-117H2	718.26	3.85	3.85	0.00	0.00	1.93	0.00
Neurons, donor1	11494-119E9	515.47	11.38	3.41	5.69	5.69	2.28	0.00
Neurons, donor2	11574-120E8	400.70	3.96	2.20	1.32	1.54	0.66	1.32
Neurons, donor3	11655-122E8	353.53	18.09	9.04	7.40	3.29	2.47	3.29
Neutrophils, donor1	11233-116C9	530.82	10.21	10.21	6.50	3.71	2.78	0.93
Neutrophils, donor2	11314-117C9	455.12	34.79	31.89	2.90	11.60	0.00	0.00
Neutrophils, donor3	11390-118C4	1344.46	9.77	5.50	2.44	1.83	2.44	1.83
Nucleus Pulposus Cell, donor1	11252-116F1	738.06	7.60	3.68	1.54	1.78	2.02	0.71
Nucleus Pulposus Cell, donor2	11409-118E5	452.26	9.44	4.88	1.30	3.26	1.30	2.28
Nucleus Pulposus Cell, donor3	11462-119B4	331.71	5.21	2.01	0.60	1.80	1.00	1.20
Olfactory epithelial cells, donor1	11933-125I7	462.37	9.64	6.61	3.03	4.40	2.06	1.38
Olfactory epithelial cells, donor2	11934-125I8	696.22	72.95	32.42	14.62	17.80	8.97	5.36
Olfactory epithelial cells, donor3	11935-125I9	440.74	7.26	4.43	2.04	2.95	2.84	1.59
Olfactory epithelial cells, donor4	11936-126A1	637.95	7.40	4.19	1.85	2.92	1.95	1.46
Oligodendrocyte - precursors, donor1	11496-119F2	269.62	1.20	1.20	0.60	0.00	0.60	0.60
Osteoblast - differentiated, donor1	11276-116H7	297.98	1.91	2.77	0.00	0.21	0.43	0.43
Osteoblast - differentiated, donor2	11353-117H3	104.02	4.57	1.14	1.14	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	224.70	6.21	5.59	0.00	0.62	0.00	1.86
Osteoblast, donor1	11277-116H8	402.21	2.15	2.15	1.37	0.20	0.20	0.20
Osteoblast, donor2	11354-117H4	654.56	7.02	5.62	2.81	1.40	0.00	0.00
Osteoblast, donor3	11426-118G4	456.06	4.44	3.02	1.24	0.89	0.71	0.36
Pancreatic stromal cells, donor1	11249-116E7	1275.41	16.34	16.09	4.13	4.13	5.56	1.77
Pericytes, donor1	11491-119E6	160.00	1.00	0.78	0.11	0.33	0.33	0.22
Pericytes, donor2	11571-120E5	82.85	0.68	1.81	0.45	0.45	0.00	0.23
Pericytes, donor3	11652-122E5	386.35	4.27	4.88	2.24	2.03	2.03	0.20
Perineurial Cells, donor1	11499-119F5	670.44	2.60	1.70	0.68	0.79	0.79	0.34
Perineurial Cells, donor2	11579-120F4	118.33	0.37	0.18	0.09	0.00	0.37	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	1513.69	4.46	6.37	1.91	1.27	1.59	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	965.74	34.53	20.08	8.57	6.86	6.37	1.71
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	1008.15	12.17	9.06	3.62	4.40	2.20	2.07
Placental Epithelial Cells, donor1	11278-116H9	5.98	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	47.68	0.00	2.22	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	49.08	1.37	0.39	0.00	0.20	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	535.75	27.53	17.09	6.65	6.33	4.11	2.53
Preadipocyte - breast, donor1	11467-119B9	575.52	5.82	8.07	3.75	1.88	1.50	0.94
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	793.74	4.83	3.00	2.35	0.78	1.04	0.78
Preadipocyte - breast, donor2	11328-117E5	461.33	14.41	9.91	3.83	4.05	2.03	2.25
Preadipocyte - omental, donor1	11468-119C1	280.36	4.90	6.50	1.49	0.21	0.43	0.64
Preadipocyte - omental, donor2	11329-117E6	551.70	6.55	7.86	2.18	0.87	2.18	1.31
Preadipocyte - omental, donor3	11403-118D8	314.86	5.59	4.30	3.72	0.57	0.29	0.57
Preadipocyte - perirenal, donor1	11469-119C2	304.14	5.91	2.95	0.00	0.98	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	902.93	3.38	4.30	0.92	1.23	0.61	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	1107.80	36.83	21.25	4.07	8.32	8.15	3.90
Preadipocyte - subcutaneous, donor3	11428-118G6	799.66	12.09	11.24	2.89	2.72	2.21	1.87
Preadipocyte - visceral, donor1	11280-116I2	1556.96	12.02	12.95	5.03	1.40	2.14	2.14
Preadipocyte - visceral, donor2	11357-117H7	1098.45	46.02	23.01	4.14	7.82	8.28	3.22
Preadipocyte - visceral, donor3	11429-118G7	1094.96	20.38	12.33	4.60	6.27	3.24	2.09
Prostate Epithelial Cells (polarized), donor1	11253-116F2	89.91	2.26	1.96	0.60	0.15	0.91	0.45
Prostate Epithelial Cells, donor2	11331-117E8	1193.94	26.41	20.99	29.66	5.55	7.45	3.93
Prostate Epithelial Cells, donor3	11404-118D9	285.61	4.59	4.78	3.31	0.98	1.71	0.80
Prostate Stromal Cells, donor1	11254-116F3	1743.36	20.73	23.12	10.71	5.92	5.70	2.28
Prostate Stromal Cells, donor2	11332-117E9	1308.52	38.91	20.98	6.45	10.76	6.28	5.38
Prostate Stromal Cells, donor3	11405-118E1	928.99	22.32	17.73	5.01	5.11	3.23	4.28
Renal Cortical Epithelial Cells, donor1	11516-119H4	601.49	0.73	3.28	1.09	0.00	0.73	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	658.25	5.75	3.26	2.22	1.39	0.69	0.62
Renal Epithelial Cells, donor1	11517-119H5	442.81	2.03	1.01	0.00	0.51	0.00	0.51
Renal Epithelial Cells, donor2	11597-120H4	436.75	7.11	2.85	1.42	2.85	2.13	0.00
Renal Epithelial Cells, donor3	11678-122H4	824.79	6.46	4.45	2.12	2.54	0.95	0.85
Renal Glomerular Endothelial Cells, donor1	11514-119H2	19.06	0.68	0.00	0.68	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	126.00	1.35	1.08	0.54	0.40	0.13	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	272.85	4.66	2.89	1.11	1.78	1.33	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	70.54	1.33	0.00	0.00	0.67	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	242.98	0.88	0.88	0.66	0.44	0.88	0.22
Renal Mesangial Cells, donor2	11598-120H5	194.37	5.02	1.88	0.63	0.00	0.63	0.63
Renal Mesangial Cells, donor3	11679-122H5	103.47	0.55	1.39	0.28	0.00	0.28	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	622.20	3.22	1.88	1.07	0.81	1.07	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	357.17	5.06	2.95	0.84	0.84	0.42	1.69
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	480.77	4.24	2.70	1.93	2.12	1.16	1.16
Retinal Pigment Epithelial Cells, donor0	11215-116A9	207.94	3.11	0.78	1.56	0.26	0.00	0.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	124.50	1.14	0.57	0.00	0.00	0.28	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	152.31	1.03	0.00	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	82.80	0.25	0.25	0.25	0.25	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	366.16	3.21	2.67	1.20	1.34	0.80	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	81.30	0.89	0.89	0.00	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	87.51	3.30	0.00	1.10	0.00	1.65	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	154.29	0.58	0.58	1.74	0.00	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	27.31	0.26	0.00	0.26	0.26	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	22.24	0.40	0.40	0.00	0.10	0.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	20.30	0.00	0.11	0.00	0.00	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	31.88	0.12	0.25	0.12	0.12	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	20.86	0.58	0.47	0.00	0.23	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	23.34	0.00	0.23	0.00	0.00	0.46	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	24.51	0.55	0.14	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	23.75	0.61	0.15	0.15	0.30	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	18.28	0.00	0.00	0.00	0.00	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	23.96	0.14	0.57	0.29	0.43	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	19.85	0.54	0.11	0.11	0.00	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	21.24	0.66	0.22	0.22	0.22	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	27.15	0.38	0.00	0.00	0.00	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	21.24	0.19	0.28	0.00	0.28	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	31.76	0.19	0.19	0.00	0.19	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	34.64	0.13	0.27	0.13	0.00	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	21.71	0.58	0.49	0.00	0.10	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	23.30	0.00	0.38	0.19	0.57	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	30.01	0.21	0.32	0.11	0.11	0.11	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	22.42	1.12	0.56	0.00	0.56	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	22.56	0.51	0.17	0.00	0.17	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	31.00	0.36	0.00	0.00	0.00	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	24.65	0.61	0.49	0.12	0.49	0.25	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	21.22	0.13	0.27	0.13	0.27	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	36.32	0.00	0.00	0.00	0.24	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	23.02	0.40	0.00	0.00	0.00	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	21.51	0.23	0.00	0.23	0.00	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	27.37	0.41	0.00	0.21	0.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	26.32	2.43	1.55	0.00	0.66	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	26.95	0.21	0.21	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	35.26	0.40	0.13	0.00	0.00	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	24.52	0.17	0.00	0.00	0.51	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	23.52	0.00	0.39	0.19	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	43.16	0.34	0.34	0.34	0.00	0.52	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	30.31	0.27	0.00	0.00	0.14	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	26.76	1.64	0.82	0.16	0.33	0.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	19.94	0.17	0.34	0.00	0.34	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	19.38	0.30	0.15	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	22.92	0.53	0.27	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	8.57	0.14	0.28	0.14	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	7.14	0.00	0.00	0.24	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	29.63	0.40	0.00	0.00	0.00	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	22.88	0.28	0.28	0.00	0.09	0.09	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	17.82	0.70	0.35	0.00	0.70	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	20.25	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	56.30	0.37	0.86	0.00	0.12	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	56.91	0.87	0.58	0.00	0.00	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	52.93	1.22	2.43	0.00	1.83	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	53.05	0.90	0.60	0.30	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	58.81	2.04	1.36	0.68	0.23	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	159.65	1.50	1.20	0.90	0.30	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	66.83	2.13	1.42	0.94	0.24	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	60.19	2.56	1.07	1.49	0.85	0.43	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	99.16	1.80	1.80	0.60	1.20	1.20	0.00
Schwann Cells, donor1	11498-119F4	314.27	3.01	2.82	0.56	2.44	0.94	0.19
Schwann Cells, donor2	11578-120F3	496.75	3.40	0.00	0.00	6.80	3.40	0.00
Schwann Cells, donor3	11659-122F3	276.26	5.48	3.72	2.85	1.75	0.88	0.66
Sebocyte, donor1	11220-116B5	1803.26	6.57	10.96	3.83	2.74	1.10	2.19
Sebocyte, donor2	11301-117B5	760.10	20.68	9.19	22.06	6.89	2.76	2.30
Sebocyte, donor3	11378-118B1	521.88	8.66	7.21	4.53	2.27	1.03	2.27
Sertoli Cells, donor1	11255-116F4	680.86	1.66	9.94	3.31	3.31	1.66	0.00
Sertoli Cells, donor2	11333-117F1	324.80	25.42	2.82	0.00	2.82	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	729.16	4.66	7.74	2.11	1.41	1.06	1.76
Skeletal Muscle Cells, donor2	11358-117H8	88.91	4.34	0.72	0.00	0.72	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	674.68	5.85	8.36	0.84	7.52	0.00	1.67
Skeletal Muscle Cells, donor4	11451-119A2	401.53	6.44	4.08	2.04	3.61	1.41	0.63
Skeletal Muscle Cells, donor5	11455-119A6	314.23	5.80	3.12	0.74	1.64	1.49	1.04
Skeletal Muscle Cells, donor6	11459-119B1	441.08	8.00	7.39	2.92	2.31	1.85	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	470.76	4.91	4.41	1.64	1.01	1.76	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	400.24	9.70	8.42	3.14	2.85	1.28	1.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	407.85	7.54	4.07	1.98	1.69	1.39	0.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	210.29	1.43	1.85	0.34	0.76	0.51	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	527.62	5.79	2.90	2.17	3.62	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	364.77	7.84	5.37	2.48	1.79	1.51	0.83
Skin - palm, donor1	10286-104F7	666.15	5.37	8.06	0.00	0.00	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	583.54	13.69	6.49	10.67	1.59	2.88	0.86
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	1913.05	69.52	26.99	31.90	15.54	13.90	4.91
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	453.62	10.78	6.62	5.97	3.76	1.82	0.91
Small Airway Epithelial Cells, donor1	11256-116F5	1084.54	17.24	14.32	18.21	3.06	4.59	1.95
Small Airway Epithelial Cells, donor2	11334-117F2	959.14	27.99	14.91	16.60	5.49	4.22	4.22
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	2067.94	14.17	9.30	8.46	3.38	3.38	2.33
Small Airway Epithelial Cells, donor3	11406-118E2	709.93	10.19	5.47	9.44	2.17	2.32	2.17
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	541.56	15.43	6.17	4.94	3.70	1.23	2.78
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	4106.01	41.13	35.80	10.00	9.34	14.01	6.23
Smooth Muscle Cells - Aortic, donor0	11210-116A4	899.96	5.29	5.29	1.18	1.18	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	821.65	8.84	7.07	1.33	0.88	1.10	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	834.81	3.15	5.91	1.97	0.39	1.58	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	1019.02	4.64	2.32	1.55	1.55	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	281.21	7.01	3.00	1.00	1.00	2.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	961.22	6.12	8.92	1.86	1.06	1.73	0.80
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	814.58	22.17	12.86	3.55	4.88	5.10	2.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	729.77	14.08	11.52	3.20	2.18	2.30	2.82
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	137.40	0.98	1.30	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	153.57	0.30	0.00	0.30	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	118.73	1.85	1.28	1.00	0.28	0.28	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	382.61	1.46	0.98	0.81	1.14	0.16	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	390.59	7.31	3.35	1.22	2.74	2.74	1.52
Smooth Muscle Cells - Carotid, donor1	11285-116I7	1381.02	6.06	7.83	2.27	1.77	1.26	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	716.12	18.36	0.00	6.12	6.12	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	1102.92	37.67	17.17	2.86	6.68	3.34	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	423.55	4.87	1.92	2.36	0.88	0.44	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	391.73	11.62	6.67	3.66	2.80	1.72	1.29
Smooth Muscle Cells - Colonic, donor3	11396-118D1	401.46	7.03	4.20	1.78	2.52	1.57	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	929.16	3.09	4.49	1.24	1.39	0.62	1.55
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	628.40	12.93	6.47	5.39	1.08	3.23	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	529.27	5.08	2.99	2.99	2.39	1.79	1.20
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	580.04	1.02	2.05	2.05	1.37	1.02	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	603.50	5.03	2.36	1.49	1.18	0.71	0.71
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	1687.05	22.95	49.72	8.96	6.24	5.84	7.95
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	1770.82	43.92	24.35	8.42	8.65	4.78	6.83
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	1299.40	25.96	22.94	6.04	17.51	4.83	5.43
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	736.76	5.56	3.44	3.44	1.32	1.85	1.06
Smooth Muscle Cells - Prostate, donor1	11257-116F6	1924.82	15.18	16.25	6.13	2.80	3.46	2.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	1540.45	40.45	27.92	8.64	6.64	5.26	5.89
Smooth Muscle Cells - Prostate, donor3	11465-119B7	535.23	3.55	6.34	3.04	0.51	0.76	1.52
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	1160.65	7.24	8.59	2.41	2.11	1.21	1.06
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	769.67	7.50	9.00	2.25	6.00	1.50	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	314.01	99.50	42.64	0.00	5.17	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	1243.13	6.98	9.30	1.86	2.33	0.47	1.86
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	1548.98	34.33	22.21	8.58	12.12	5.05	3.03
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	1796.06	45.13	29.46	11.91	9.09	10.66	7.21
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	434.24	4.42	3.24	1.18	1.47	0.88	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	589.23	2.00	1.00	0.67	0.17	0.08	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	304.12	3.27	1.87	1.87	1.40	0.47	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	733.98	3.02	4.75	1.44	1.01	0.43	0.86
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	651.41	14.53	6.12	3.57	3.57	2.29	1.53
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	506.19	7.33	6.96	1.32	3.01	1.32	0.94
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	646.74	3.91	2.10	1.82	1.40	0.56	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	235.28	1.17	0.84	0.25	0.34	0.17	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	279.52	0.95	1.43	0.95	0.48	0.95	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	685.30	3.67	2.45	1.22	2.45	0.00	1.96
Smooth Muscle Cells - Uterine, donor1	11258-116F7	1389.32	15.02	20.55	5.97	4.42	2.43	1.77
Smooth Muscle Cells - Uterine, donor3	11466-119B8	819.81	9.36	7.31	1.46	4.97	2.34	2.34
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	703.00	11.47	8.36	2.92	1.36	2.14	1.55
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	394.30	11.64	8.20	6.61	2.64	2.38	1.85
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	1208.83	36.08	31.99	12.27	13.39	13.39	5.21
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	1808.54	42.76	23.36	14.73	12.94	10.42	5.03
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	1339.44	27.25	11.64	6.53	5.96	5.11	2.84
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	922.83	21.27	11.03	6.70	3.15	5.12	3.54
Smooth muscle cells - airway, control, donor1	11966-126D4	773.79	26.92	19.05	12.19	8.13	4.57	3.81
Smooth muscle cells - airway, control, donor2	11967-126D5	912.44	18.37	15.17	8.79	6.39	3.99	5.59
Smooth muscle cells - airway, control, donor3	11968-126D6	696.40	22.57	10.87	10.03	6.69	5.43	3.34
Smooth muscle cells - airway, control, donor4	11969-126D7	826.88	11.92	8.25	3.21	3.67	5.50	1.38
Synoviocyte, donor1	11291-117A4	969.86	9.76	13.13	3.87	3.53	3.03	1.18
Synoviocyte, donor2	11368-117I9	1772.46	34.53	29.84	9.55	8.88	4.86	5.53
Synoviocyte, donor3	11440-118H9	1032.82	21.22	17.43	8.49	5.59	5.14	2.90
Trabecular Meshwork Cells, donor1	11532-120A2	654.63	2.86	2.14	1.79	0.71	0.00	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	535.15	3.96	1.98	1.98	7.93	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	392.01	3.70	1.85	1.39	2.32	1.39	0.69
Tracheal Epithelial Cells, donor1	11292-117A5	578.56	3.73	3.66	2.65	0.72	0.72	0.36
Tracheal Epithelial Cells, donor2	11369-118A1	444.16	5.03	6.19	1.55	1.16	1.55	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	451.83	9.16	6.30	4.58	4.01	2.29	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	359.72	4.80	3.20	1.35	1.60	1.35	1.60
Urethra, donor2	10319-105A4	302.14	8.99	1.80	3.60	1.80	5.40	1.80
Urothelial Cells, donor1	11520-119H8	569.84	3.98	3.72	4.52	1.33	0.27	1.33
Urothelial Cells, donor2	11600-120H7	634.09	9.61	8.01	8.01	4.41	1.60	2.00
Urothelial Cells, donor3	11681-122H7	428.61	4.13	3.21	4.58	0.92	1.38	0.92
Urothelial cells, donor0	11216-116B1	1162.18	9.14	4.90	8.47	1.78	2.23	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	885.33	6.23	7.12	6.23	1.78	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	892.08	10.01	1.43	2.86	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	468.90	10.27	9.58	2.05	4.79	3.42	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	649.77	4.82	1.38	1.72	1.72	1.03	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	701.30	6.39	2.32	1.74	0.58	1.74	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	948.57	3.12	2.08	1.04	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	961.85	3.67	2.75	2.75	0.92	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	479.27	11.87	7.30	2.74	4.56	1.83	2.74
Wilms' tumor cell line:G-401	10809-111A8	4.07	0.00	0.00	0.00	0.00	0.12	0.00
Wilms' tumor cell line:HFWT	10597-108E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	1934.56	16.20	13.69	14.52	4.19	8.66	4.47
achilles tendon, donor2	10292-104G4	766.68	14.47	6.20	8.27	2.07	2.07	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	103.26	1.78	0.25	2.29	0.00	0.00	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	33.95	0.24	0.24	0.12	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	496.96	10.40	7.59	3.65	1.69	1.97	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	585.59	3.17	4.23	1.27	0.85	0.63	0.85
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	1517.58	20.42	10.34	7.08	4.63	3.54	2.99
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	446.81	5.73	2.64	2.64	3.08	3.08	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	670.12	8.58	5.72	2.86	4.08	2.45	2.04
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	443.05	3.11	3.49	1.55	0.78	0.39	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	296.44	3.90	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	350.43	5.81	2.79	0.70	2.56	1.63	1.39
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	301.36	3.62	2.59	1.29	1.04	1.81	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	213.05	2.34	1.46	1.17	0.88	1.17	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	505.19	2.79	2.32	0.93	1.86	1.39	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	525.99	9.46	4.11	2.06	2.88	2.47	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	71.52	0.61	0.31	0.00	0.00	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	99.85	0.85	1.28	0.85	0.00	0.85	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	181.37	0.61	0.61	0.91	0.00	0.00	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	140.57	0.48	1.44	0.72	0.00	0.00	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	165.72	4.68	3.34	0.89	0.67	0.67	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	80.38	1.00	0.00	0.33	0.00	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	35.31	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	61.40	0.38	0.75	0.00	0.00	0.00	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	3288.88	28.35	10.47	6.11	7.41	6.98	5.67
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	35.61	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	139.18	0.47	0.71	1.41	0.00	0.47	0.47
adipose tissue, adult, pool1	10010-101C1	513.60	5.43	3.26	0.93	1.55	1.40	1.40
adipose, donor1	10184-103D4	2.93	0.00	0.00	0.59	0.00	0.00	0.00
adipose, donor2	10185-103D5	0.41	0.00	0.00	0.00	0.00	0.00	0.00
adipose, donor3	10186-103D6	0.82	0.54	0.00	0.00	0.27	0.00	0.00
adipose, donor4	10187-103D7	13.00	0.87	0.00	0.00	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	5.52	0.00	0.00	0.16	0.16	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	54.57	0.00	3.64	0.00	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	865.02	6.79	6.79	3.22	2.50	3.93	0.71
amniotic membrane cells, donor1	12235-129G3	7.65	0.23	0.00	0.00	0.00	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	43.28	0.00	0.34	0.00	0.00	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	0.59	0.00	0.00	0.00	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	77.08	1.19	1.19	0.00	1.19	0.00	1.19
amygdala, adult, donor10252	10151-102I7	188.98	4.06	3.85	0.61	1.22	0.41	2.64
amygdala, newborn, donor10223	10360-105E9	150.73	2.58	0.65	0.00	0.65	0.65	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	1548.59	6.37	12.10	3.44	0.89	1.15	2.04
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	5.01	0.00	0.00	0.00	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	641.94	16.08	7.65	3.14	4.71	4.51	1.37
appendix, adult	10189-103D9	492.52	6.21	6.60	3.49	2.72	2.33	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	8.25	0.00	0.00	0.34	0.00	0.00	0.00
artery, adult	10190-103E1	183.42	6.79	1.36	2.72	4.08	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	3900.40	26.37	21.59	16.23	5.36	3.19	4.20
b cell line:RPMI1788	10427-106D4	1159.42	4.76	4.76	2.38	1.34	0.74	0.74
basal cell carcinoma cell line:TE 354.T	10702-109G9	671.70	11.10	8.32	4.99	3.33	0.83	1.66
bile duct carcinoma cell line:HuCCT1	10432-106D9	1448.29	5.76	6.05	3.37	1.39	1.29	1.49
bile duct carcinoma cell line:TFK-1	10496-107C1	112.31	1.17	1.00	0.33	0.17	0.00	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	537.43	5.59	1.68	1.68	0.56	0.00	1.12
bladder, adult, pool1	10011-101C2	674.44	8.26	7.93	4.13	2.72	3.15	1.41
blood, adult, pool1	10053-101G8	571.37	13.29	8.86	13.29	2.21	2.21	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	470.13	0.86	0.86	0.00	0.00	0.00	1.71
bone marrow, adult	10192-103E3	292.20	18.90	8.10	1.35	6.75	2.02	1.35
brain, adult, donor1	10084-102B3	26.65	0.00	0.00	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	121.49	1.34	0.78	0.11	0.56	0.33	0.33
brain, fetal, pool1	10085-102B4	42.74	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	94.15	0.66	0.99	0.66	1.65	0.00	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
breast, adult, donor1	10080-102A8	251.28	5.05	5.05	1.26	1.26	3.16	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	707.47	7.50	4.57	5.72	2.16	3.05	1.14
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	81.63	0.62	0.62	0.31	0.00	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	1003.30	22.56	11.28	10.36	6.45	2.76	2.76
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	0.47	0.00	0.00	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	327.16	1.53	1.20	1.64	0.98	0.44	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	39.93	1.06	2.40	0.53	1.06	0.00	0.27
caudate nucleus - adult, donor10196	10177-103C6	323.52	9.21	4.61	2.30	2.30	1.15	1.15
caudate nucleus, adult, donor10252	10164-103B2	98.89	2.18	0.50	0.33	1.17	0.67	0.33
caudate nucleus, adult, donor10258	10379-105H1	34.39	0.00	0.00	0.00	0.00	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	510.16	13.18	6.96	4.39	4.39	1.10	1.46
cerebellum - adult, donor10196	10173-103C2	75.75	2.91	2.91	0.00	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	121.06	2.56	3.42	1.28	1.49	0.85	1.49
cerebellum, adult, pool1	10083-102B2	47.60	0.69	0.00	0.34	0.69	0.34	1.03
cerebellum, newborn, donor10223	10357-105E6	215.04	6.64	1.66	0.83	0.83	0.00	0.00
cerebral meninges, adult	10188-103D8	56.23	0.25	0.76	0.00	0.00	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	287.97	8.04	4.39	0.73	0.73	1.46	0.00
cervical cancer cell line:D98-AH2	10552-107I3	147.09	0.00	1.15	0.29	0.00	0.00	0.14
cervical cancer cell line:ME-180	10553-107I4	779.20	3.15	3.65	3.98	0.83	1.99	1.16
cervix, adult, pool1	10013-101C4	710.36	7.56	6.93	2.94	2.73	2.10	1.78
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	465.53	4.60	4.04	2.65	0.84	0.56	0.84
chondrosarcoma cell line:SW 1353	10700-109G7	354.00	2.61	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:SCH	10785-110H2	0.12	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	74.65	0.85	0.00	0.28	0.28	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	496.26	6.16	8.15	3.48	1.19	0.89	1.29
chorionic membrane cells, donor3	12240-129G8	86.82	2.20	0.55	0.00	0.55	0.55	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	140.36	8.08	3.03	2.02	2.02	1.01	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	514.25	3.46	2.88	2.31	0.96	1.54	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	130.51	0.42	0.21	0.00	0.00	0.63	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	2.31	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	2.90	0.24	0.00	0.00	0.24	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	8.55	0.00	0.00	0.00	0.41	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	17.08	0.00	0.00	0.29	0.29	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	456.62	1.82	1.82	1.30	0.52	1.04	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	519.11	24.69	11.89	8.23	5.26	4.11	3.20
clear cell carcinoma cell line:TEN	10636-108I6	145.22	1.39	0.87	0.35	0.69	0.35	0.52
colon carcinoma cell line:CACO-2	10513-107D9	53.63	0.00	0.18	0.00	0.00	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	9.50	0.00	0.00	0.00	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	192.79	2.38	1.19	1.19	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	197.52	1.88	2.35	0.59	0.35	0.71	0.47
colon, fetal, donor1	10070-101I7	215.68	6.80	6.80	1.85	1.85	3.09	1.85
common myeloid progenitor CMP, donor1	12130-128D6	788.37	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	450.66	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	352.27	3.40	2.97	0.85	0.42	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	244.66	1.81	1.96	1.06	0.60	0.75	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	279.06	2.40	0.71	1.69	0.56	0.28	0.14
corpus callosum, adult, pool1	10042-101F6	513.12	2.54	1.55	0.44	0.77	0.11	0.55
cruciate ligament, donor2	10295-104G7	826.68	17.02	12.16	4.05	3.24	4.86	1.62
diaphragm, fetal, donor1	10069-101I6	105.14	1.61	0.80	3.21	0.80	0.00	1.61
diencephalon, adult	10193-103E4	87.60	2.16	1.20	0.24	0.00	0.48	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	19.52	0.69	0.23	0.23	0.69	0.23	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	572.12	1.80	1.28	2.82	0.51	0.77	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	1996.07	19.98	20.46	11.07	3.13	4.57	7.22
ductus deferens, adult	10196-103E7	125.58	1.50	2.49	1.00	0.50	0.00	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	177.15	5.76	2.88	0.00	1.44	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	221.43	17.66	9.56	1.47	3.68	1.47	0.74
dura mater, adult, donor1	10041-101F5	670.69	4.71	2.31	0.74	1.24	0.50	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	638.24	5.77	13.32	1.55	1.33	2.22	2.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	41.41	0.43	0.57	0.14	0.00	0.14	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	579.00	3.08	1.23	0.62	1.85	0.00	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	1099.75	25.12	10.59	6.36	6.05	2.42	3.94
embryonic pancreas cell line:1C3IKEI	10606-108F3	774.04	5.87	2.16	1.23	2.16	0.93	1.23
embryonic pancreas cell line:2C6	10603-108E9	679.06	0.00	1.31	1.31	0.00	0.00	2.63
endometrial carcinoma cell line:OMC-2	10497-107C2	350.61	1.34	2.01	1.68	0.34	1.01	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	391.29	4.53	2.72	2.90	1.09	1.63	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	286.57	9.81	3.70	3.70	1.45	1.77	1.77
epidermoid carcinoma cell line:A431	10426-106D3	1422.39	4.34	5.89	5.00	2.33	2.22	1.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	881.86	2.42	1.98	2.42	0.88	0.66	0.55
epididymis, adult	10197-103E8	287.38	3.98	5.65	1.67	1.47	0.84	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	1482.62	16.32	9.93	6.39	2.84	5.85	2.84
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	996.08	8.26	3.15	2.75	1.57	3.15	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	268.26	7.34	3.80	1.70	1.44	0.92	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	304.61	6.30	2.26	1.38	2.07	1.67	1.08
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	273.35	7.73	4.26	1.57	1.90	2.02	0.34
esophagus, adult, pool1	10015-101C6	585.04	7.96	6.48	5.95	2.23	6.16	2.76
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	0.88	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	94.17	0.00	0.00	0.00	0.00	4.83	0.00
eye - muscle lateral, donor2	10298-104H1	265.13	4.21	2.10	0.00	0.00	2.10	0.00
eye - muscle medial, donor2	10299-104H2	47.62	1.49	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	182.29	2.29	4.59	2.29	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	762.22	4.37	4.37	1.46	2.91	1.46	0.00
eye, fetal, donor1	10054-101G9	216.35	4.32	4.32	1.53	3.81	0.51	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	1330.46	11.28	7.31	5.90	2.69	5.51	3.08
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	1888.91	15.43	12.82	7.83	4.51	6.65	3.09
frontal lobe, adult, pool1	10040-101F4	42.50	0.09	0.00	0.09	0.00	0.00	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	14.11	0.00	0.00	0.00	0.00	0.30	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	1084.34	4.02	5.67	1.37	1.65	0.73	1.10
gall bladder, adult	10198-103E9	628.69	11.59	9.66	3.62	2.66	3.62	3.38
gamma delta positive T cells, donor1	11937-126A2	833.73	3.76	4.29	2.15	2.15	0.54	0.54
gamma delta positive T cells, donor2	11938-126A3	496.74	3.36	1.87	2.24	0.75	1.12	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	1165.49	40.98	22.39	11.62	9.72	9.08	5.70
gastric adenocarcinoma cell line:MKN45	10612-108F9	1674.98	11.41	10.25	12.57	2.90	3.29	2.71
gastric cancer cell line:AZ521	10549-107H9	0.16	0.00	0.00	0.00	0.00	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	0.23	0.00	0.00	0.00	0.00	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	160.64	1.26	1.26	0.92	0.57	0.23	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	1419.89	4.62	8.54	1.96	1.12	0.56	1.40
glassy cell carcinoma cell line:HOKUG	10688-109F4	367.14	5.74	2.24	4.99	2.00	2.24	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	599.75	3.80	2.53	1.37	0.53	0.11	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	550.24	2.39	1.83	0.84	0.42	1.54	0.14
glioblastoma cell line:T98G	10485-107A8	2759.66	18.76	12.03	10.26	3.42	4.41	4.97
glioma cell line:GI-1	10413-106B8	152.88	0.59	0.59	0.00	0.29	0.00	0.59
globus pallidus - adult, donor10196	10175-103C4	194.62	5.10	0.00	0.73	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	483.80	9.52	3.91	1.95	4.15	2.93	3.42
globus pallidus, adult, donor10258	10367-105F7	90.37	4.11	5.48	5.48	0.00	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	264.33	7.99	0.53	0.53	1.07	0.53	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	1713.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	579.20	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	308.37	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	640.31	14.08	8.64	3.84	2.56	2.56	3.52
hIPS +CCl2, biol_rep1	14383-156B9	13.77	0.00	0.92	0.46	0.46	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	17.83	0.00	0.46	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	11.59	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	5.75	1.44	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	8.92	0.00	0.69	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	108.14	2.21	0.00	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	447.39	5.46	4.02	0.86	0.57	2.01	1.15
heart - mitral valve, adult	10205-103F7	229.01	3.29	2.39	0.00	0.60	0.30	1.20
heart - pulmonic valve, adult	10206-103F8	287.62	3.40	3.14	0.78	1.05	1.31	0.52
heart - tricuspid valve, adult	10207-103F9	540.38	8.33	4.16	0.83	5.83	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	51.01	1.22	1.02	0.20	0.61	0.41	0.00
heart, adult, diseased, donor1	10051-101G6	48.54	0.85	0.00	0.00	1.28	0.43	0.00
heart, adult, pool1	10016-101C7	100.04	0.46	0.23	0.23	0.23	0.00	0.00
heart, fetal, pool1	10046-101G1	94.36	0.92	0.41	0.00	0.00	0.21	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	500.43	6.48	2.16	1.54	1.23	2.78	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	20.22	0.00	0.00	1.19	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	0.10	0.00	0.00	0.00	0.00	0.00	0.00
hepatoma cell line:Li-7	10484-107A7	97.76	1.00	0.67	0.11	0.11	0.00	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	294.97	2.81	0.90	0.40	0.30	1.01	0.70
hippocampus - adult, donor10196	10169-103B7	177.91	0.95	3.79	0.00	3.79	0.95	1.89
hippocampus, adult, donor10252	10153-102I9	298.80	6.53	3.88	1.43	2.25	1.02	3.06
hippocampus, adult, donor10258	10374-105G5	38.34	1.00	0.00	0.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	158.97	1.76	1.06	0.35	1.76	1.06	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	14.65	0.00	0.61	0.00	0.61	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	16.69	0.00	0.39	0.20	0.20	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	10.16	0.25	0.00	0.00	0.25	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	0.56	0.00	0.56	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	1.81	0.26	0.52	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	0.76	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	0.58	0.00	0.29	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	1.08	0.22	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	2.50	0.00	0.00	0.00	0.00	0.00	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	6.16	0.24	0.00	0.24	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	8.20	0.48	0.00	0.48	0.16	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	6.06	0.00	0.67	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	8.92	0.31	0.00	0.00	0.16	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	12.77	2.46	1.47	1.47	1.47	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	3.49	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	4.39	0.19	0.00	0.00	0.00	0.00	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	3.05	0.00	0.00	0.44	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	1.50	0.50	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	0.57	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	0.91	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	0.63	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	4.74	0.16	0.33	0.16	0.00	0.16	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	8.13	0.00	0.00	0.29	0.29	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	5.98	0.30	0.00	0.30	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	8.87	0.00	0.18	0.18	0.00	0.00	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	12.55	0.00	0.29	0.57	0.29	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	13.47	0.82	0.41	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	7.39	0.35	0.00	0.35	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	3.17	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	5.14	0.30	0.30	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	2.07	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	1.99	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	1.28	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	10.74	1.28	0.00	0.51	0.77	0.26	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	5.30	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	12.43	0.67	1.01	0.34	0.00	0.00	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	5.55	0.24	0.24	0.00	0.00	0.00	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	8.02	0.45	0.00	0.00	0.00	0.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	4.39	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	3.36	0.00	0.31	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	0.99	0.33	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	0.72	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	0.71	0.00	0.00	0.36	0.00	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	7.16	1.19	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	16.12	0.14	0.14	0.14	0.00	0.00	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	10.78	1.08	0.27	0.27	0.00	0.00	0.00
immature langerhans cells, donor1	11904-125F5	1998.92	19.61	13.80	7.75	6.05	3.39	3.39
immature langerhans cells, donor2	11905-125F6	1242.06	8.71	3.17	2.38	6.34	0.00	2.38
insula, adult, pool1	10039-101F3	36.53	0.19	0.19	0.00	0.00	0.00	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	273.77	1.30	3.90	2.93	0.00	0.33	0.98
kidney, adult, pool1	10017-101C8	84.21	0.70	0.50	0.50	0.10	0.20	0.00
kidney, fetal, pool1	10045-101F9	57.08	0.07	0.28	0.28	0.07	0.00	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	1580.27	6.25	8.24	2.13	0.85	2.41	1.56
large cell lung carcinoma cell line:NCI-H460	10839-111E2	71.06	1.80	1.11	0.97	0.41	0.28	0.83
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	738.40	1.28	1.47	1.65	0.73	0.55	0.00
left atrium, adult, donor1	10079-102A7	152.56	3.81	2.72	1.09	0.00	3.81	0.00
left ventricle, adult, donor1	10078-102A6	95.06	1.52	1.52	0.51	0.00	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	151.31	0.82	0.27	0.00	0.00	0.00	0.27
leiomyoma cell line:10964C	10569-108B2	1220.37	58.92	33.77	10.78	12.21	9.70	6.47
leiomyoma cell line:15242A	10570-108B3	1916.31	89.13	41.30	21.74	17.39	10.33	10.33
leiomyoma cell line:15425	10571-108B4	1774.01	101.74	59.98	24.04	24.77	17.48	8.74
leiomyosarcoma cell line:Hs 5.T	10722-110A2	507.95	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	221.66	5.23	5.23	2.09	0.00	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	697.02	3.78	1.53	1.65	1.30	2.13	1.30
liposarcoma cell line:KMLS-1	10782-110G8	1083.63	12.65	12.34	5.47	2.97	2.34	3.12
liposarcoma cell line:SW 872	10726-110A6	1689.06	9.38	6.70	4.87	3.17	2.68	2.07
liver, adult, pool1	10018-101C9	101.45	1.46	0.81	0.81	0.16	0.16	0.16
liver, fetal, pool1	10086-102B5	57.38	1.88	0.00	0.00	0.00	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	354.06	4.96	1.75	0.87	0.87	0.44	1.31
locus coeruleus, adult, donor10252	10165-103B3	402.14	7.94	3.32	1.48	3.14	1.29	2.21
locus coeruleus, adult, donor10258	10375-105G6	186.78	11.57	4.51	1.41	2.26	0.56	1.13
locus coeruleus, newborn, donor10223	10362-105F2	799.18	28.60	11.78	7.15	6.73	5.05	2.94
lung adenocarcinoma cell line:A549	10499-107C4	383.63	1.11	1.94	0.55	0.14	0.14	0.69
lung adenocarcinoma cell line:PC-14	10408-106B3	876.24	3.45	0.69	0.00	0.00	0.69	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	2.11	0.00	0.00	0.00	0.00	0.00	0.00
lung, adult, pool1	10019-101D1	567.60	4.49	3.43	1.77	1.65	1.65	1.65
lung, fetal, donor1	10068-101I5	1146.48	10.27	3.14	3.42	3.14	2.28	3.14
lung, right lower lobe, adult, donor1	10075-102A3	555.82	16.50	22.45	2.75	3.21	7.79	2.75
lymph node, adult, donor1	10077-102A5	483.30	14.67	8.52	3.31	6.15	1.42	3.31
lymphangiectasia cell line:DS-1	10727-110A7	326.14	3.29	3.29	0.66	0.66	1.32	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	93.57	1.81	0.75	0.30	0.15	0.15	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	1038.93	3.40	6.80	4.25	0.85	0.85	0.85
mature adipocyte, donor1	12231-129F8	168.27	0.00	0.00	0.00	0.44	0.00	0.44
mature adipocyte, donor2	12232-129F9	122.44	0.42	0.83	0.00	0.00	0.00	0.00
mature adipocyte, donor3	12233-129G1	177.09	2.37	0.71	0.24	0.00	0.24	0.24
mature adipocyte, donor4	12234-129G2	178.20	1.32	1.32	0.00	0.53	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	385.98	1.43	3.57	0.48	0.71	1.19	1.19
medial frontal gyrus - adult, donor10196	10170-103B8	14.66	0.00	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	164.04	2.94	0.74	0.55	0.74	0.55	0.74
medial frontal gyrus, adult, donor10258	10368-105F8	21.29	0.00	0.00	0.00	0.64	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	181.26	7.68	3.84	1.28	2.99	0.43	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	21.60	2.70	0.84	1.01	1.01	0.51	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	96.99	0.64	1.49	0.42	0.42	0.42	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	5.78	0.00	0.00	0.00	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	88.30	1.08	0.36	0.36	0.00	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	373.16	7.14	4.54	0.65	4.54	4.54	4.54
medulla oblongata, adult, donor10252	10155-103A2	763.49	15.33	6.97	2.01	4.33	2.94	5.11
medulla oblongata, adult, pool1	10038-101F2	836.84	2.86	2.45	0.73	1.63	0.65	1.06
medulla oblongata, newborn, donor10223	10361-105F1	664.85	11.46	5.55	2.43	2.78	1.39	2.78
medulloblastoma cell line:D283 Med	10838-111E1	43.18	1.11	0.44	0.22	0.22	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	930.01	4.04	3.06	1.35	1.83	1.47	1.35
melanoma cell line:COLO 679	10514-107E1	333.35	2.59	5.89	1.01	0.72	0.72	1.15
melanoma cell line:G-361	10465-106H6	593.69	10.86	17.37	6.24	1.36	4.07	3.53
meningioma cell line:HKBMM	10691-109F7	2293.33	124.28	59.88	32.56	22.07	17.19	13.03
merkel cell carcinoma cell line:MKL-1	10843-111E6	5.29	0.88	0.00	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	59.36	1.30	1.04	0.26	0.52	0.52	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	922.29	10.59	6.44	3.84	2.30	1.84	1.99
mesenchymal precursor cell - adipose, donor2	11748-123G2	361.38	5.09	3.27	0.55	1.45	0.91	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	1265.08	16.98	15.74	6.21	5.38	4.56	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	843.97	9.13	6.04	2.67	2.81	1.55	0.84
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	657.81	9.63	4.81	2.31	1.73	0.96	0.96
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	1084.84	19.43	18.05	6.25	4.86	4.16	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	748.50	10.81	10.81	2.75	2.06	2.06	1.03
mesenchymal precursor cell - cardiac, donor2	11753-123G7	606.82	8.74	5.87	2.30	1.73	1.38	1.04
mesenchymal precursor cell - cardiac, donor3	11754-123G8	803.65	7.56	7.30	3.05	2.12	1.33	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	998.62	9.72	10.80	4.32	4.86	1.49	1.35
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	976.63	10.39	8.39	3.56	4.41	2.42	1.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	958.75	12.19	10.21	3.62	2.31	2.63	1.98
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	963.62	10.65	8.16	2.35	1.94	2.21	0.83
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	1362.82	20.25	12.57	7.33	3.14	5.59	5.93
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	1034.30	11.23	8.78	4.08	5.10	3.27	1.02
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	802.30	14.74	7.91	4.67	3.59	1.80	3.59
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	719.60	7.55	6.21	2.28	1.97	2.28	0.93
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	983.10	22.57	15.28	7.30	6.38	3.65	3.19
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	1483.13	19.72	14.68	8.39	5.87	3.78	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	404.38	7.02	4.48	0.75	0.75	1.20	0.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	1052.56	9.80	8.05	4.11	4.55	2.10	1.49
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	825.78	14.36	10.68	2.58	3.31	1.84	2.58
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	761.46	15.45	16.31	6.30	2.86	4.58	3.15
mesenchymal stem cell line:Hu5/E18	10568-108B1	421.86	21.05	13.05	6.32	4.63	2.95	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	722.00	8.68	5.48	2.74	1.83	0.91	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	741.26	11.77	9.46	4.60	3.33	2.30	1.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	770.09	9.16	8.11	4.19	1.83	1.57	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	809.34	15.71	12.02	6.78	2.16	2.46	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	736.90	18.12	8.71	4.00	3.77	3.53	2.59
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	758.82	10.49	8.12	2.71	2.71	4.74	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	775.33	10.61	5.11	4.72	0.39	2.36	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	651.52	12.51	8.34	4.63	2.32	3.24	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	627.95	0.00	0.00	0.00	0.00	48.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	897.84	14.42	11.83	4.33	2.60	2.60	1.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	799.15	7.36	7.36	3.57	0.89	3.35	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	807.10	14.66	7.45	4.57	4.81	2.40	2.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	1092.66	22.73	20.53	4.40	7.33	1.47	2.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	703.87	8.06	6.04	4.03	1.34	1.01	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	733.20	11.87	7.37	4.09	4.91	2.05	2.46
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	686.43	11.60	7.30	3.01	3.44	3.44	3.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	771.10	10.94	16.41	5.47	2.73	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	614.63	15.49	5.16	25.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	683.67	21.76	13.32	7.15	1.30	3.25	3.25
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	743.50	27.64	14.55	11.64	5.82	2.91	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	743.11	26.65	12.26	4.80	2.67	1.60	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	651.76	13.90	12.27	3.27	4.09	5.72	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	610.68	19.44	8.94	6.61	1.17	1.94	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	650.61	25.18	12.59	2.10	6.30	4.20	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	596.08	21.86	7.95	2.98	1.99	3.97	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	686.48	38.14	33.37	9.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	572.80	12.45	8.89	4.74	3.56	2.37	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	720.11	28.02	19.50	4.87	4.87	1.22	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	676.31	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	704.32	22.17	9.50	2.53	4.43	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	278.68	7.93	2.41	1.38	1.38	0.69	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	270.80	8.60	6.45	8.60	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	295.39	7.98	0.00	3.99	0.00	3.99	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	192.86	0.00	3.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	160.95	2.85	2.04	0.81	0.81	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	141.41	0.79	1.59	0.79	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	103.76	2.36	1.18	1.77	0.59	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	110.66	1.56	0.94	0.00	0.31	0.62	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	109.61	5.35	2.67	1.34	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	206.97	5.91	0.00	4.73	2.37	3.55	3.55
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	215.71	10.27	5.14	5.14	2.57	5.14	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	211.34	5.51	1.38	0.00	0.69	2.75	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	106.88	2.97	0.00	0.49	0.49	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	81.87	3.36	1.12	1.12	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	103.68	1.91	0.64	1.27	1.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	81.00	1.61	0.40	0.40	1.21	0.40	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	95.95	4.36	0.00	4.36	0.00	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	78.56	1.27	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	118.95	2.43	1.21	0.00	0.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	131.05	9.04	9.04	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	101.31	2.47	3.29	1.65	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	241.09	1.59	0.99	1.19	0.20	0.40	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	226.50	1.62	2.27	0.32	0.97	1.62	1.95
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	274.01	7.13	7.13	6.11	3.06	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	503.69	0.77	0.00	0.00	0.00	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	996.23	3.54	3.78	1.89	1.18	2.83	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	77.15	0.46	0.00	0.00	0.00	0.00	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	3222.29	59.83	21.37	25.64	12.82	8.55	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	2260.20	27.33	19.32	16.03	7.09	4.83	2.16
mesothelioma cell line:Mero-25	10850-111F4	137.08	1.36	0.91	0.68	0.23	0.68	0.68
mesothelioma cell line:Mero-41	10851-111F5	1211.37	14.67	8.80	6.85	5.13	5.13	2.44
mesothelioma cell line:Mero-48a	10852-111F6	1362.91	14.61	12.84	6.20	2.88	3.76	2.66
mesothelioma cell line:Mero-82	10853-111F7	942.42	14.45	9.20	6.04	3.94	3.94	3.42
mesothelioma cell line:Mero-83	10854-111F8	707.61	7.49	7.49	3.06	1.87	2.21	2.72
mesothelioma cell line:Mero-84	10855-111F9	1060.39	13.14	10.36	5.06	3.03	4.04	2.27
mesothelioma cell line:Mero-95	10856-111G1	161.91	2.28	2.28	1.45	0.83	1.24	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	1058.65	9.44	10.77	3.64	4.64	2.82	2.65
mesothelioma cell line:NCI-H226	10846-111E9	934.28	12.13	7.06	4.52	3.62	2.90	2.71
mesothelioma cell line:NCI-H2452	10848-111F2	792.96	11.96	5.81	4.27	3.25	2.90	1.37
mesothelioma cell line:NCI-H28	10845-111E8	84.48	3.05	1.02	0.51	1.02	0.00	0.00
mesothelioma cell line:No36	10857-111G2	81.55	1.30	0.65	0.65	0.98	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	1104.94	17.07	9.48	5.96	6.50	3.79	1.63
migratory langerhans cells, donor1	11901-125F2	96.54	1.15	0.77	1.15	0.38	0.19	0.19
migratory langerhans cells, donor2	11902-125F3	53.00	0.73	0.98	0.12	0.12	0.12	0.12
migratory langerhans cells, donor3	11903-125F4	67.13	1.08	0.72	0.00	0.00	0.00	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	296.77	17.30	6.86	8.49	2.61	1.63	1.96
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	295.02	8.05	5.93	3.81	1.91	2.54	1.06
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	219.99	0.46	0.46	0.69	0.00	0.46	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	520.83	4.95	4.57	2.47	0.95	0.95	1.52
myelodysplastic syndrome cell line:SKM-1	10772-110F7	776.13	4.62	7.21	3.51	1.48	1.66	0.74
myeloma cell line:PCM6	10474-106I6	792.84	5.73	6.13	4.15	1.38	1.19	0.79
myxofibrosarcoma cell line:MFH-ino	10600-108E6	1003.42	8.12	3.04	0.00	4.57	1.52	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	566.45	2.75	2.55	1.96	0.78	0.59	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	277.67	1.56	1.45	1.00	0.45	0.56	0.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	245.99	1.47	1.62	0.81	0.59	0.29	0.37
nasal epithelial cells, donor2	12227-129F4	540.40	1.66	4.97	5.52	1.10	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	6.44	0.00	0.00	0.23	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	45.46	0.19	0.37	0.37	0.00	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	0.63	0.00	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	19.19	0.37	0.19	0.00	0.19	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	6.81	0.00	0.32	0.00	0.00	0.16	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	33.01	0.20	0.00	0.40	0.60	0.40	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	451.42	2.93	1.60	1.33	1.33	1.06	1.06
neutrophil PMN, donor1	12133-128D9	401.62	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	292.17	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	217.82	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	194.66	2.20	1.18	0.34	0.34	0.17	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	369.34	7.69	8.66	3.53	1.92	1.60	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	3440.11	113.78	69.90	29.69	31.01	19.71	10.25
nucleus accumbens, adult, pool1	10037-101F1	63.56	0.19	0.09	0.00	0.09	0.00	0.00
occipital cortex - adult, donor10196	10172-103C1	28.85	0.00	0.00	2.06	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	283.93	5.10	3.76	0.81	0.81	0.27	3.22
occipital cortex, newborn, donor10223	10355-105E4	105.18	2.55	0.36	0.36	0.00	0.36	0.36
occipital lobe, adult, donor1	10076-102A4	39.62	1.84	0.79	0.52	0.00	0.00	0.26
occipital lobe, fetal, donor1	10073-102A1	11.59	0.43	0.00	0.43	0.00	0.00	0.00
occipital pole, adult, pool1	10036-101E9	62.44	0.24	0.16	0.00	0.08	0.08	0.00
olfactory region, adult	10195-103E6	92.47	0.96	1.15	0.57	0.57	0.76	0.57
optic nerve, donor1	10277-104E7	128.07	0.00	0.00	2.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	582.98	3.19	3.42	3.19	0.46	0.91	1.03
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	583.76	2.34	2.47	1.79	0.55	0.55	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	860.50	42.84	23.54	27.94	11.18	8.80	3.73
oral squamous cell carcinoma cell line:SAS	10544-107H4	612.20	5.31	2.89	5.08	1.62	1.73	0.69
osteoclastoma cell line:Hs 706.T	10704-109H2	702.58	4.41	8.23	1.18	1.18	1.76	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	1295.92	5.61	0.93	0.93	0.00	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	43.47	0.42	0.21	0.00	0.21	0.00	0.00
ovary, adult, pool1	10020-101D2	174.18	0.70	2.10	0.35	0.52	0.61	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	432.45	3.48	2.02	2.20	2.20	1.28	1.65
pancreas, adult, donor1	10049-101G4	523.94	15.99	4.70	6.58	5.64	2.82	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	742.23	31.34	17.55	6.47	8.18	4.09	4.43
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	834.70	3.48	7.95	1.66	0.99	0.83	1.16
paracentral gyrus, adult, pool1	10035-101E8	54.64	0.27	0.09	0.09	0.00	0.18	0.18
parietal cortex, adult, donor10258	10373-105G4	22.75	0.73	0.00	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	58.31	0.00	0.00	0.94	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	164.75	2.28	2.28	0.00	0.57	0.29	0.57
parietal lobe, adult, pool1	10034-101E7	65.03	0.53	0.35	0.09	0.09	0.09	0.00
parietal lobe, fetal, donor1	10072-101I9	12.61	0.97	0.00	0.00	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	159.64	3.36	1.87	0.75	0.75	0.75	0.37
parotid gland, adult	10199-103F1	2026.97	27.75	16.03	3.70	8.02	3.08	3.08
penis, adult	10200-103F2	465.68	15.04	9.13	10.21	6.98	1.61	4.30
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	119.93	2.42	2.97	1.12	0.74	0.74	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	1235.49	13.55	7.14	11.80	1.46	4.95	3.64
pineal gland - adult, donor10196	10179-103C8	76.11	1.29	1.29	0.00	0.00	0.00	1.29
pineal gland, adult, donor10252	10160-103A7	203.13	1.18	1.18	0.59	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	106.60	3.14	0.63	0.63	1.88	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	30.35	0.00	1.01	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	32.83	0.00	0.00	0.00	0.52	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	5.11	0.00	0.00	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	249.94	2.15	1.08	0.86	0.22	0.00	0.86
plasma cell leukemia cell line:ARH-77	10840-111E3	297.83	4.63	3.05	1.46	1.06	0.66	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	436.57	4.36	4.51	0.93	1.40	0.47	0.47
pons, adult, pool1	10033-101E6	144.42	0.77	0.26	0.17	0.26	0.09	0.00
postcentral gyrus, adult, pool1	10032-101E5	50.74	0.26	0.09	0.00	0.00	0.09	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	361.81	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	137.70	5.51	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	82.15	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	111.29	1.75	0.44	1.02	0.15	0.00	0.29
prostate cancer cell line:PC-3	10439-106E7	418.91	4.54	2.18	1.82	0.54	0.36	0.91
prostate, adult, pool1	10022-101D4	420.36	2.45	3.81	1.72	0.54	1.27	1.36
putamen, adult, donor10196	10176-103C5	35.17	0.24	0.24	0.00	0.00	0.00	0.00
putamen, adult, donor10252	10152-102I8	62.74	0.00	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	21.86	1.09	1.09	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	19.57	0.00	0.00	0.48	0.00	0.00	0.00
putamen, newborn, donor10223	10365-105F5	615.47	17.24	6.75	4.50	3.00	6.75	2.25
rectal cancer cell line:TT1TKB	10469-106I1	0.58	0.00	0.00	0.00	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	157.18	4.17	4.17	1.39	0.00	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	160.06	2.54	2.12	0.42	0.42	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	540.13	8.28	6.63	2.49	1.66	1.66	1.24
retina, adult, pool1	10030-101E3	531.19	3.68	2.19	0.70	0.70	0.50	0.60
retinoblastoma cell line:Y79	10475-106I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	0.00	0.00	0.00	0.25	0.00	0.00	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	4.50	0.00	0.00	0.00	0.00	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	940.50	3.03	1.52	0.00	0.76	0.76	0.00
salivary acinar cells, donor1	11771-123I7	1021.48	22.66	14.89	3.56	3.88	2.91	2.43
salivary acinar cells, donor2	11772-123I8	748.19	17.62	10.60	3.03	2.48	2.20	3.17
salivary acinar cells, donor3	11773-123I9	479.99	3.31	2.65	1.99	1.32	0.00	2.65
salivary gland, adult, pool1	10093-102C3	2542.33	12.58	11.44	1.14	3.43	2.86	1.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	1262.48	7.93	8.43	4.13	2.28	1.69	3.04
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	1026.23	8.35	7.29	4.00	1.53	2.47	3.06
seminal vesicle, adult	10201-103F3	299.98	6.35	6.88	4.23	3.17	1.59	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	100.33	2.67	1.46	0.73	0.49	0.73	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	766.72	13.08	8.56	2.26	2.77	1.51	3.52
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	736.59	15.05	14.05	4.01	3.01	8.03	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	26.19	0.27	0.00	0.40	0.00	0.13	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	57.81	0.00	0.66	0.44	0.22	0.11	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	5063.47	32.13	36.39	18.71	7.35	6.84	7.74
skeletal muscle - soleus muscle, donor1	10282-104F3	39.01	0.00	0.00	0.00	0.00	0.00	1.42
skeletal muscle, adult, pool1	10023-101D5	215.65	1.44	2.16	0.48	0.24	0.48	0.24
skeletal muscle, fetal, donor1	10066-101I3	277.38	15.08	4.02	4.02	1.01	6.03	1.01
skin, adult, donor1	10074-102A2	997.43	20.36	6.79	0.00	6.79	0.00	6.79
skin, fetal, donor1	10065-101I2	277.74	25.88	6.31	8.21	1.89	4.42	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	2.52	0.63	0.32	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	326.51	5.98	5.01	1.54	1.16	1.54	0.96
small cell lung carcinoma cell line:LK-2	10541-107H1	859.90	2.97	5.60	2.97	0.66	0.82	2.14
small cell lung carcinoma cell line:NCI-H82	10842-111E5	4.02	0.16	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	6.97	0.00	0.00	0.22	0.00	0.00	0.00
small intestine, adult, pool1	10024-101D6	167.34	1.07	1.31	0.84	0.84	1.19	0.48
small intestine, fetal, donor1	10064-101I1	78.62	1.72	1.23	1.47	1.72	1.23	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	502.18	10.08	5.94	1.81	6.20	2.84	0.78
somatostatinoma cell line:QGP-1	10781-110G7	1.07	0.00	0.00	0.00	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	644.17	32.35	16.52	6.19	7.57	3.90	3.90
spinal cord, adult, donor10252	10159-103A6	1888.95	24.84	14.19	4.34	7.10	3.15	5.13
spinal cord, adult, donor10258	10369-105F9	849.53	24.21	8.99	4.84	10.38	7.61	2.77
spinal cord, fetal, donor1	10056-101H2	270.77	11.59	4.27	0.61	2.44	3.05	2.44
spinal cord, newborn, donor10223	10359-105E8	754.95	15.15	17.45	6.43	12.40	4.59	4.59
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	773.95	7.32	3.73	2.54	0.75	1.34	1.34
spleen, adult, pool1	10025-101D7	406.06	2.53	2.75	0.88	0.66	0.55	0.55
spleen, fetal, pool1	10044-101F8	442.57	3.10	2.38	0.79	0.48	0.40	0.64
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	238.91	2.28	1.35	0.31	0.31	0.00	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	975.77	5.51	4.75	6.46	0.76	1.90	0.95
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	24.46	0.70	1.40	0.35	0.70	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	1482.02	30.10	19.16	19.55	5.86	8.99	5.47
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	38.83	0.56	0.23	0.34	0.11	0.00	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	964.54	16.10	11.01	3.81	6.35	4.24	1.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	364.26	2.54	0.00	0.00	0.85	0.00	0.00
stomach, fetal, donor1	10062-101H8	231.75	2.14	0.00	2.14	1.07	2.14	0.00
submaxillary gland, adult	10202-103F4	1045.36	38.17	22.22	6.84	9.68	3.99	6.27
substantia nigra - adult, donor10196	10178-103C7	325.64	0.00	0.00	54.27	0.00	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	521.55	9.55	5.82	3.12	3.12	3.32	1.04
substantia nigra, adult, donor10258	10371-105G2	151.55	4.14	0.00	0.00	0.52	1.03	0.52
substantia nigra, newborn, donor10223	10358-105E7	510.85	19.78	7.77	0.71	2.83	0.71	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	0.46	0.00	0.00	0.00	0.00	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	64.76	0.85	0.17	0.00	0.34	0.08	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	10.68	0.00	0.00	0.00	0.00	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	53.62	0.44	0.00	0.88	0.44	0.00	0.44
tenocyte, donor1	11763-123H8	1323.09	57.60	14.66	10.12	10.47	6.98	4.89
tenocyte, donor2	11765-123I1	1815.97	36.24	18.31	7.25	9.92	4.96	3.05
tenocyte, donor3	11768-123I4	1348.85	44.48	14.09	12.23	8.15	5.93	3.71
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	49.12	0.68	0.17	0.34	0.00	0.68	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	16.34	0.46	0.15	0.15	0.15	0.15	0.15
teratocarcinoma cell line:PA-1	10807-111A6	195.89	2.01	0.77	0.77	0.31	0.62	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	62.20	0.76	1.52	0.38	0.25	0.25	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	22.69	0.76	0.00	0.38	0.38	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	155.85	0.87	2.29	0.65	0.55	0.44	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	2.93	0.00	0.00	0.00	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	172.33	2.25	1.50	0.97	0.11	0.75	0.43
testis, adult, pool2	10096-102C6	55.03	1.35	0.00	0.90	0.45	0.45	0.00
thalamus - adult, donor10196	10168-103B6	305.80	2.21	1.10	2.21	2.21	3.31	0.00
thalamus, adult, donor10252	10154-103A1	363.98	7.66	3.13	0.94	2.66	1.09	2.66
thalamus, adult, donor10258, tech_rep1	10370-105G1	143.18	4.62	0.00	0.00	1.54	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	136.86	4.28	2.31	0.66	1.81	0.82	0.00
thalamus, newborn, donor10223	10366-105F6	197.33	7.48	2.30	3.45	0.00	1.15	0.00
throat, adult	10209-103G2	361.77	15.48	7.74	2.25	2.25	2.50	1.50
throat, fetal, donor1	10061-101H7	176.73	5.48	2.44	0.61	0.91	0.91	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	3.38	0.00	0.00	0.00	0.00	0.20	0.00
thymus, adult, pool1	10027-101D9	264.64	1.99	3.18	0.89	0.50	1.19	0.50
thymus, fetal, pool1	10043-101F7	307.66	1.87	1.87	0.42	0.83	0.31	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	1094.13	13.56	9.57	3.46	4.79	4.52	3.19
thyroid carcinoma cell line:TCO-1	10783-110G9	452.32	5.17	2.10	1.96	0.98	1.96	1.54
thyroid, adult, pool1	10028-101E1	284.70	2.05	2.80	0.93	0.84	0.65	1.21
thyroid, fetal, donor1	10060-101H6	179.29	4.75	3.69	1.85	1.05	1.05	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	517.38	12.32	9.24	3.08	6.16	0.00	0.00
tongue, adult	10203-103F5	585.16	21.40	16.28	10.23	5.12	3.95	2.33
tongue, fetal, donor1	10059-101H5	158.82	3.15	5.52	0.79	0.79	1.58	0.79
tonsil, adult, pool1	10047-101G2	895.17	3.21	3.51	1.60	1.20	0.90	1.00
trachea, adult, pool1	10029-101E2	623.80	3.35	2.45	2.04	1.64	2.04	1.47
trachea, fetal, donor1	10058-101H4	215.81	5.77	4.23	1.54	3.46	1.15	1.92
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	1783.78	14.88	13.11	7.44	4.61	4.96	4.25
transitional-cell carcinoma cell line:5637	10418-106C4	553.69	2.23	3.14	1.42	0.71	0.91	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	428.23	3.76	3.29	2.66	1.25	0.94	0.94
tridermal teratoma cell line:HGRT	10694-109G1	595.49	3.81	0.00	3.81	0.00	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	466.76	3.47	2.96	0.42	1.02	2.12	1.02
umbilical cord, fetal, donor1	10057-101H3	93.89	4.17	0.00	2.09	2.09	0.00	2.09
uterus, adult, pool1	10100-102D1	1400.69	6.83	3.75	3.41	4.10	1.37	2.22
uterus, fetal, donor1	10055-101H1	489.92	15.36	7.17	3.07	2.56	3.07	1.02
vagina, adult	10204-103F6	318.58	3.88	2.58	0.65	3.23	0.65	0.00
vein, adult	10191-103E2	412.53	11.62	7.67	2.19	2.19	1.97	2.63
xeroderma pigentosum b cell line:XPL 17	10563-108A5	714.32	5.61	2.94	3.47	0.80	1.07	0.53